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Abstract
Practice Problem: Low pneumococcal vaccine uptake among high-risk adults is partly due to
underutilized or lack of nurse-driven vaccine protocols, limited understanding of vaccine
intervals and indications by nurses, and lack of proper training. Currently, physician-driven
orders are the only avenue for high-risk adults to obtain this vaccine in ambulatory sites.
PICOT: In adults 65 years or older within an ambulatory setting, does the use of an adult
pneumococcal vaccine protocol, compared to a physician order (no vaccine protocol) impact the
rate of vaccination over 2 months?
Evidence: Utilization of two or more interventions provided higher immunization rates.
Interventions with stronger evidence rate include nurse-driven vaccine protocols, vaccine
reminders, and use of electronic health system alerts. Review of programs and toolkits proved
efficient interventions of vaccine programs based on CDC program evaluation framework.
Intervention: The program evaluation yielded best practices for adult pneumococcal vaccine
compliance utilizing nurse-driven protocols based on CDC recommendations and a competencybased orientation toolkit to support staff members when working in ambulatory settings.
Outcome: A CBO toolkit was created to facilitate the ordering and administration of
pneumococcal vaccines based on approved protocol to increase vaccine uptake. CBO toolkits
offer nurses autonomy and increased competency with safe injection practices.
Conclusion: Adult vaccine programs with nurse-driven protocols in combination with other
modalities, prove effective to increase pneumococcal vaccine rates among high-risk groups and
expands access to preventive health services provided by nursing staff. A CBO toolkit increases
competency of injection practices to nurses in ambulatory settings.
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Evidence-Based Best Practice Toolkit for
Competency-Based Orientation in Integrating an Adult Pneumococcal Protocol to Improve
Vaccine Rate: A Program Review
Vaccine-preventable diseases (VPD) account for complications and infectious diseases
with low vaccine rates among high-risk adults (Tan et al., 2020). Negative outcomes for
preventable disease due to low immunization rates are strongly linked to hospitalizations or
readmissions, disease complications, disabilities, income loss, and demise (Ozawa et al., 2016).
According to public health institutions, 80% of the economic burden correlates to the
unvaccinated population and longer life expectancy, especially among adults (Sauer, et al., 2021;
Tan et al., 2020; Williams et al., 2016). Integration of effective adult immunization programs
will support healthy aging and decrease the mortality and morbidity rates (Sauer et al., 2021).
Evaluation of vaccine programs allow quality improvement committees to improve ineffective
practices or develop new ones and improve adherence to vaccine guidelines (Pennant et al.,
2015). Limited access to immunizations and underutilization of vaccines places communities at
risk for susceptible diseases. To close the vaccine gap among this aging population, this program
evaluation and development of a competency-based orientation (CBO) toolkit, will identify best
practices on adult vaccine programs and a tool to orient nurses when on the assessment and
administration of pneumococcal vaccines.
Significance of the Practice Problem
Low pneumococcal vaccine uptake among adults in the ambulatory setting yields poor
health outcomes. Managing and treating infectious diseases among high-risk adults, especially
those 65 years and older becomes challenging while dealing with comorbidities that potentially
be exacerbated. Efforts to inoculate the population have been a burden by physicians alone in the
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current vaccine era leading to innovative ways to improve the vaccination rate. The nursing staff
must understand vaccine schedules and indication, disease prevention and treatment, as well as
preventive measures and integrate them into the plan of care to recognize early signs of illness or
deterioration (Jump et al., 2018). Lower respiratory infections like pneumonia and bronchitis are
the leading cause of hospitalization among the geriatric population in the United States (Jump et
al., 2018). Strong and consistent vaccine campaigns, hand hygiene protocols, surveillance, and
control of disease outbreaks will help control infectious diseases (Center for Disease Control,
2016).
Currently, one clinical site for the organization revealed that only 88% (774/884) of
eligible adults 65-years and older met the pneumococcal vaccine schedule, however, this
percentage fell below the established organizational goal of 90% as recommended by the
Healthy People 2030 benchmark. Low vaccine uptake in part is due to lack of nurse-driven
protocols, limited understanding of vaccine intervals and indications, fear about the safety of
vaccines, underutilization of best practice alerts in electronic health records (EHR) and access to
services (Colmegna et al., 2021). Harris (2021) argued the importance of improving
pneumococcal vaccination rates among immunosuppressed patients in ambulatory settings that
are at a greater risk of developing respiratory tract infections by integrating best practices in the
clinical setting.
Global and Regional Statistics
Vaccine-preventable diseases continue to impact populations worldwide. Over the last
three decades, a cumulative disease burden of 25 million pneumococcal cases in the United
States has been reported and a projected cost of 653 billion over the next 30 years to treat
influenza and pneumococcal disease (Tailbird et al., 2021). The World Health Organization
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(WHO) reported 1.5 million deaths each year because of vaccine-preventable diseases (2015).
According to Healthy People 2030, an estimated 713.9 hospitalizations related to pneumonia
infections per 1000,000 adults 65-years and older were recorded in 2016 (Healthy People 2030,
n.d.). Approximately “…320,000 people get pneumococcal pneumonia every year, leading to
150,000 hospitalizations and 5,000 deaths, mostly among the elderly” (Centers for Disease
Control, 2016, para. 1). Despite public health recommendations of two pneumococcal vaccine
doses among adults 65 years and older, the pneumonia prevention vaccine rate was 61 % in 2014
in comparison to the Healthy People 2020 goal of 90% (Hughes et al., 2018). In 2018, California
reported an estimate of 6,917 deaths related to lower respiratory infections among adults
(National Center for Health Statistics, 2020).
Society and Population Impact
High-risk populations are the most vulnerable and account for most serious lower
respiratory tract numbers leading to a financial burden on their retirement funds and overall
healthcare costs of $1.8 billion annually (Huang et al., 2011). Inoculation of different
populations prevents millions of vaccine-preventable diseases annually, interrupts disease
transmission domestically and abroad, and reduces financial impact on communities
(Vanderslott, 2018). Overall, unvaccinated adults account for $7.1 billion of economic burden
and add up to approximately 2.3 million hospital days (CDC, 2014; Huang et al., 2011).
Integrating adult vaccine programs in primary care and specialty settings will mitigate
pneumococcal infections and complications among high-risk adults. These programs will
improve uptake of vaccines and avoid wasting costly vaccines due to underutilization. Over the
years vaccines have proven to be effective with mild to moderate side effects, adverse effects to
vaccines are rare.
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Purpose of the Program Evaluation Project
The purpose of this program review was to gather evidence to support a proposed Doctor
of Nursing Practice (DNP) project. The guiding objectives of this program evaluation and
subsequent competency-based orientation toolkit development were to: 1) Apply the CDC
program evaluation framework in the appraisal of an adult pneumococcal vaccine program to
identify best practice recommendations to increase vaccination rates in ambulatory settings
within 10-weeks and 2) develop a competency-based orientation toolkit for nurse-driven adult
pneumococcal vaccination programs for community-based practice settings to increase
competency-based skillsets and improve vaccine administration practices within 10-weeks.
This program evaluation focused on best practices for an adult pneumococcal vaccine
program utilizing nurse-driven protocols based on CDC recommendations and to elaborate a
competency-based orientation toolkit to support staff members when working in ambulatory
settings. Nurse-driven protocols facilitate the ordering and administration of pneumococcal
vaccines based on approved policies of a health entity. Protocols can be embedded in electronic
health systems to support clinical decision making. Knowledge-deficit among staff members for
vaccine guidelines is among other barriers to vaccine protocols according to the U.S. Community
Preventive Services Task Force [CPSTF] (2016). Other concerns that interfere with the
implementation of vaccine protocols is the lack of training, concern for additional workload,
team members hesitancy to administer vaccines without a physician’s order, and concern that
vaccines would interfere with other care services (CPSTF, 2016).
The use of a vaccine protocol is an evidence-based intervention adaptable to inpatient and
ambulatory clinical settings and supports onboarding of the nursing team during orientation. A
qualitative study revealed that a major set-back to a vaccine protocol integration is provider
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acceptance of this process (Dempsey et al., 2015). During an informational session, clinicians
would be provided the rational for the impact of integrating a vaccine protocol with workflow
improvements, enhance access to preventive health services, and the collaboration of other team
members like nurses to support them with the assessment and administration of vaccines to highrisk populations. In addition, the project leader provided periodic updates of the vaccine uptake
numbers once the protocol in place compliance was ensured with the process. By the end of the
PowerPoint session, staff had a better understanding of the pneumococcal vaccine criteria by
providing feedback via a survey following the presentation. At the end of a two-week
preceptorship period, the orientee was able to properly assess, recommend, administer, and
document inoculation of the vaccine referencing the available toolkit to support use of the nurse
driven vaccine protocol via direct observation of the preceptor. Volunteer preceptors within the
clinical site were randomly assigned.
Program Problem Statement
The following clinical question has been formulated to guide this DNP project. In adults
65 years or older within an ambulatory setting, does the use of an adult pneumococcal vaccine
protocol, compared to physician order (no standing order protocol) impact the rate of vaccination
over 2 months? The population was focused on adults 65 years and older since they are
considered a high-risk population. An intervention of a competency-based orientation toolkit on
the use of a pneumococcal vaccine order protocol improved staff compliance on usage and
improve access to preventive health services without the need to schedule a visit with a
physician. The comparison to the intervention is a physician order needed to activate the vaccine
in the system or missed opportunities to inoculate. The outcome of this evidence-based
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intervention has proven to be effective in increasing vaccine uptake among under-immunized
adults and familiarize staff members with underutilized vaccine protocols (Hurley et al., 2020).
A CBO toolkit was developed to guide adult pneumococcal vaccination programs and
reduce the utilization gap of immunization protocols, familiarize nurses with vaccine guidelines,
and increase job satisfaction. The evaluation of current adult vaccine programs identified best
practices available that supported the uptake of immunizations to mitigate vaccine preventable
diseases among high-risk populations, especially in adults 65 years and older.
Utility of Program Review
Integration of a nurse-driven adult pneumococcal vaccine program will contribute to
enhance access to preventive health services for high-risk populations, increase vaccine uptake
and mitigate missed opportunities, relieve burden on physicians alone of ordering the vaccine,
maximize nurses’ scope of practice, increase compliance with practice guidelines and
organizational policy. The evaluation of existing adult immunization programs utilizing the CDC
program performance and evaluation framework allowed insight on the effectiveness of such
programs, the interventions, and analysis of their outcomes. Evaluating best practices through the
scrutiny of available programs supported this project leader with the development of an effective
adult pneumococcal vaccine program and CBO toolkit. Both will increase protocol utilization,
improve vaccine rate, and ease the transitioning orientation for nurses new to the ambulatory
setting. Potential for workflow improvements will enhance immunization programs and decrease
the probability of VPD in high-risk groups in an array of settings like hospitals, long-term care
facilities, and ambulatory settings. This objective will increase the rate of vaccination, reducing
missed opportunities to inoculate, reduce hospitalizations rates and complications, and increasing

PROGRAM EVALUATION CBO TOOLKIT

10

staff adherence to guidelines and institutional policy (CDC, 2019; Quinn et al., 2020; Sheth et
al., 2021).
Supporting new hires to ambulatory practices will facilitate comfort when managing
nurse schedules and improve their immunization assessment and administration skills. The
utilization of AVP can easily be applied in settings that manage high-risk clients like
rheumatology, endocrinology, and infusion centers, as well as other settings like pharmacies.
Analytical Framework
The following analytical model will guide this program evaluation. The Centers for
Disease Control and Prevention (CDC) Program Performance and Evaluation Office (PPEO) is
an effective framework offered to appraise immunization programs. This framework offered a
systematic approach to effectively implement or improve best practices available while
evaluating adult pneumococcal vaccine programs and its relation to key stakeholders. This
program evaluation framework consists of six key steps focused on stakeholder engagement,
program description, evaluation design, evidence credibility or strength, justification of
conclusions, and sharing utilization of findings by ensuring use and sharing lessons learned
(CDC, 2017). The John’s Hopkins Evidence-Based Practice (JHNEBP) framework comprised of
three steps focused on practice question, evidence, and translation, served as a foundational basis
since its application follows a systematic approach like the PPEO. Both frameworks highlighted
the integration of all team members vital to the development of a project through identification
of a clinical inquiry or population of interest, planning or description of a program or
intervention, appraisal and summary of best evidence gathered, and sharing findings with
stakeholders (CDC, 2017; Dang & Dearholt, 2017). For this DNP project, the PPEO framework
was utilized.
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Step one and two of the CDCs PPEO framework aims to identify stakeholders invested
and description of the program. Key team members identified are the nurses involved with the
utilization of an adult pneumococcal vaccine program/protocol, physicians willing to share
acceptance of nurses involvement with application of program, practice managers support of
program implementation within clinical site, regulatory team involved with the results of
program outcome to meet organizational quality metrics, informatics or analytics team to
integrate other electronic health system functions to support program integration and data
collection, and other ambulatory nurses compliance with program participation. For stakeholders
to buy in, an informational session will be provided on the relevance of best practice applications
to improve vaccination rates and integrate utilization of a nurse-driven pneumococcal vaccine
protocol/program and review the workflow that integrate best practices. An explanation of the
proposed workflow will include purpose of the program which aims to improve vaccination rates
and facilitate the orientation or training for nurses with use the CDCs pneumococcal vaccine
guideline road map and utilization of a CBO toolkit. The toolkit will provide access to institution
policy, vaccination assessment checklist based on CDC guidelines, and handouts with related
vaccine administration guidelines.
Step three of the program evaluation framework evaluates the design of the project. An
outcome of this program evaluation was the creation of a CBO toolkit to guide onboarding
nurses in an array of settings working with vaccine administration. Analysis of the toolkits
effectiveness to support the nurses’ orientation process will be appraised and need for revision.
Step four focuses on the collection of the trustworthy evidence that supports the development of
an APV program and CBO toolkit. Evaluation of toolkit utilization rate produced a tangible
output of its usefulness. The application of clinical judgement, analysis and translation of
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evidence summarizes step 5 of this system. Identification of themes on best practices provided a
basis for the development of a CBO toolkit. The last step, number six, culminates with sharing
the findings and recommendations of the evidence gathered to help sustain the program or need
for revisions during scheduled quarterly meetings with use of PowerPoint presentations that
include graphs and stakeholder feedback. A systematic approach will support the use of decision
making when evaluating a programs sustainability and feasibility.
Evidence Search Strategy, Results, and Evaluation
A diligent literature review search was conducted in the following databases: CINAHL,
OVID Medline, PubMed, and ProQuest. Articles published between January 1sts 2005 and May
31st, 2021, were included. Key terms and subject headings searched were Pneumococcal disease,
pneumococcus pneumonia, vaccine compliance, adult vaccine programs, nurse-driven protocols,
inoculation practices, best practice alerts, and clinical protocols. Inclusion criteria: adults 65
years and older and geriatrics; quasi-experimental studies and systematic review; ambulatory or
primary care; and publication date 2005 to present. Exclusion criteria applied: pediatric, and
young adults. During the search process of literature in several databases, a total of 100 results
were generated by the search. The database Cumulative Index of Nursing and Allied Health
(CINAHL) produced 53 citations using the mentioned keyword; the Ovid Medline yield 3
articles; PubMed database generated 23 articles and ProQuest resulted in only 1, while Google
Scholar outputted 20 citations.
Evidence Search Results
After screening the titles and abstracts, a sum of ten studies remained for this project and
included in a PRIMSA diagram (see Figure 1). One of the ten articles was a systematic review
with a level II of evidence and B grade of evidence based on the Johns Hopkins EBP model.
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Seven of ten articles yield a level II of evidence with four B and three a level A grade of
evidence. Three of the articles revealed a III level of evidence. Overall, the grade and level of
evidence support the effectiveness of the use of vaccine standing order protocols within a
multimodal approach.
The Johns Hopkins EBP model was utilized to determine each article’s level and strength
of evidence (Dang & Dearholt, 2017). Table 1 provides the articles found and is organized by
levels and grades according to the John’s Hopkins EBP tool. Appendix A and B provide details
for each article that summarizes each finding.
Evidence Evaluation
The Advisory Committee of Immunization Practices (ACIP) offers the CDC advice and
guidance on the most current pneumococcal vaccine recommendations which are published in
the Morbidity and Mortality Weekly Report (MMWR). The ACIPs role is to develop vaccine
recommendations that include age-appropriate timelines for vaccine administration, interval
between recommended doses, frequency of doses, and precautions and contraindications to guide
professionals practice (CDC, 2019). As of October 2021, ACIP recommends new doses, a 15valent PCV and a 20-valent PCV for adults 65 years-old or older and for those between 19-64
years with high-risk conditions with no prior history of a PCV (Kobayashi, 2022). The
implication for public health practice is based on the simplification of the vaccine guidelines.
Studies with effective APV programs recommended computerized reminders or best practice
alerts based on CDC guidelines to support vaccine administrators in addition to nurse-driven
protocols (Capitano et al., 2018; Tan et al., 2020; Trick, 2009).
The CDC along with the National Vaccine Advisory Committee (NVAC) have created a
set of standards to improve adult immunization practices and increase vaccine uptake rates by all
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healthcare professionals and mitigate missed opportunities (NVAC, 2014). A four-step approach
to assess, recommend, administer or refer, and document, offers a model to all healthcare
professionals along the care spectrum (CDC [NVAC], 2016). The CDC PPEO framework
highlights the importance of stakeholder engagement to the success of any program. This
recommendation provides a pathway to stakeholders that administer vaccines and to those that
do not immunize but can refer patients to professionals that do so. Assessment of the patients’
vaccine status by informed professionals along with integrated protocols and up-to-date policies
ensure inoculation at every visit. Once the patient is agreeable, health professionals will proceed
to administer the dose or refer to a site where vaccines are offered. The last practice of standard
is the effective documentation of the vaccine received by the patient whether in an electronic
health system or an immunization registry. Ensure that the patient leaves with an appointment
reminder if an additional dose is required to complete a series. These standards offer effective
practices that support the effectiveness and guidance to improve adult immunization programs.
Ensuring the health of communities through preventive services is at the core of the U.S.
Community Preventive Services Task Force [CPSTF]. This is an independent and nonfederal
agency established by the U.S. Department of Health and Human Services in 1966. The CPSTF
offers evidence-based interventions across many health topics applicable to an array of settings
that contain approaches that improve health, disease preventive strategies, healthcare policies
and system changes, to improve the delivery of services (Guide to Community Preventive
Services Task Force [CPSTF], 2016). Recommendation of strong evidence interventions found
in systematic reviews by the CPSTF to implement adult vaccination programs include the use of
provider reminders, provider assessment and feedback, client reminder and recall systems, home

PROGRAM EVALUATION CBO TOOLKIT

15

visit vaccine programs, reducing client out-of-pocket costs, standing orders, and a health care
system-based interventions implemented in combination (CPSTF, 2014).
Evaluation of these programs point out effecting interventions found in scholarly articles
reviewed by this author. Articles that mention adult vaccine programs and the use strategies that
improve access to health services with the integration of vaccine protocols and proven effective
on improving vaccination rates in health care settings among adults 65 years-old and high-risk
populations.
Critical Appraisal of the Evidence with Themes
After a close review and synthesis from the collected literature, the use of an adult
pneumococcal vaccine program in ambulatory settings improved patient outcomes and staff
compliance to inoculate. Higher immunization rates among high-risk adults were evident
especially when paired a second intervention like clinical support tools embedded in electronic
health systems, best practice alerts. The literature revealed effective correlation of increased
vaccines rates with the use of effective adult vaccine programs integrated to daily workflows in
primary and tertiary settings. Previsit planning to identify individuals in need of a vaccine was
included in workflows recommended. Many of the scholarly articles reviewed were performed in
tertiary settings and few in primary care and long-term care sites. Five of ten articles were
carried out in primary care settings within the United States. One of the ten reviewed the use of
pharmacist-driven pneumococcal immunization protocols in 56 inpatient acute settings and 38
outpatient areas. The following themes were identified during the literature appraisal.
Single Interventions
In single intervention studies, written or electronic vaccine standing order versus the use
of immunization flow sheet post-immunization policy implementation did not yield a significant

PROGRAM EVALUATION CBO TOOLKIT

16

change in vaccine rates (Gamble, 2008; Goebel, 2005). Vaccine champions, yearly staff
education, and effective computerized monitoring systems were recommended postimplementation of vaccine programs with protocols to maintain the success of vaccine programs
in any setting (Capitano, 2018; Gamble, 2008; Goebel, 2005; Tan 2020). Gamble’s (2008)
single intervention study revealed a statistical increase in vaccine rate but not significant when
evaluating the use of a standing order policy in three primary care sites pre- and postimplementation (38% versus 13%). Although vaccine rate was improved, a factor influencing
rates was the clinicians’ hesitancy to recommend inoculation leading to missed opportunities.
Capitano (2018) emphasized higher patient compliance with vaccine uptake when physicians
educate on the importance of health promotion and disease prevention with strong vaccine
recommendations. In this study, 80% (45 of 56) of inpatient settings used pneumococcal
immunization protocols in comparison to 50% (19 of 38) of outpatient settings. Computerized
standing orders for pneumococcal inoculation among adults were 51% effective compared to
31% when using electronic physician reminders as referenced in Table 2 (Capitano, 2018).
Multi-Modal Interventions
Most articles reported that multimodal interventions versus single interventions provided
statistically significant results as evidenced by Loskutova (2020), Lau (2012), Trick (2009),
Smith (2011), Kim et al. (2014), and Bond (2009). These studies highlighted the factors that
contributed to the success and effectiveness of adult immunization programs when utilizing
vaccine protocols in conjunction with a computerized generated provider and patient reminders,
immunization flow sheets, checklists, and patient outreach. Loskutova (2020) focused on adults
that met the criteria for inoculation in a large primary care setting implementing a multimodal
intervention in comparison to the use of a clinician reminder system. Post-intervention, vaccine
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rates increased by 18% in contrast to the comparison group, 16% as noted in Table 2. Although
vaccine rate was improved, a factor influencing rates was the clinicians’ hesitancy to recommend
inoculation leading to missed opportunities. Capitano (2018) emphasized higher patient
compliance with vaccine uptake when physicians educate on the importance of health promotion
and disease prevention. In this study, 80% (45 of 56) of inpatient settings used pneumococcal
immunization protocols in comparison to 50% (19 of 38) of outpatient settings. Computerized
standing orders for pneumococcal inoculation among adults were 51% effective compared to
31% when using electronic physician reminders as referenced in Table 2 (Capitano, 2018).
Pharmacy-Driven Protocols
Pharmacy-driven vaccine programs that integrated protocols were identified during the
literature review as effective interventions to improve vaccination rates. Articles revealed that
the use of pneumococcal immunization protocols (PIPs) supported recommendations from the
Advisory Committee on Immunization Practices (ACIP). A cross-sectional study of 94 surveys
for inpatient and outpatient pharmacy settings within the United States, concluded that 56% (45
inpatient settings) followed PIP and only half of the outpatient sites had pneumococcal protocols
in place. Common barriers identified to the implementation of PIPs were outdated protocols, lack
of knowledge to ACIP vaccine recommendations and lack of staff accountability (Capitano,
2018; Hurley et al., 2020). Additionally, the Immunization Action Coalition (IAC) exhorts all
licensed health care professionals who see adults to appraise, recommend, and inoculate or refer
for needed vaccines to mitigate missed opportunities and increase vaccination rates (Hurley et
al., 2020). Expansion of adult vaccine programs integrate settings like pharmacies to facilitate
access and accommodate payor requirements.
Clinical Practice Recommendation
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These studies yielded higher vaccine rate uptake by adults. Based on the scientific
evidence from the synthesized literature, adult vaccine programs that include nurse-driven
vaccine protocols in combination with other modalities proved effective towards increase
pneumococcal and influenza vaccination rates among elderly and adults 18 years of age and
older. Consistent use of adult vaccine programs and patient reminders correlated with higher
vaccine rates in ambulatory settings in comparison to hospital settings (Capitano, 2018).
Evaluated vaccine programs and practice standards strongly recommended the integration of
adult vaccine programs that included standing orders or protocols since they help expand access
to vaccines by including ancillary staff like nurses and pharmacist to mitigate missed
opportunities.
Program Review Recommendation Statement
Integration adult pneumococcal vaccine programs in ambulatory settings allows
expansion of preventive health services through nurse clinic services without the need of a
physician order. Changing the current culture of immunization practices within any organization
promotes accountability, increase ease to recommend vaccines, and improves vaccines
administrators’ skills and ineffective practices, “cultural norms define what is encouraged,
discouraged, accepted, or rejected within the group” (Groysberg et al., 2018, p.4). Evidencebased projects or quality improvement assignments enhance vaccine compliance culture in any
organization and contributes to implementation of cost-effective vaccine programs. This APV
program will reduce the time needed to seek a signed order from a clinician, close the gap for
delivery of services, and improve the patients’ experience with the delivery of care. Synthesized
evidence supports the integration of adult vaccine programs to free up clinicians from minor
assignments, shift tasks to trained licensed personnel to aid with inoculation, improve clinical
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workflow, and mitigate missed opportunities. Additionally, activating best practice alerts in
electronic systems to guide patient care, will support the clinical decision making when
recommending missing vaccines. Instituting workflows that support clinical staff, will reinforce
vaccine practice guidelines, vaccine practice standards, and pneumococcal vaccine
recommendations to identified patients.
Implementing a CBO toolkit will enhance the nursing team’s knowledge with vaccine
indications and guidelines, administration practices and vaccine adverse effects management and
reporting, effective documentation practices, and use of best practice alerts in electronic health
systems. As improvements in vaccination rates are established, the project can be disseminated
among other primary care settings that would benefit from this intervention like specialty clinics
that service high-risk adults in need of pneumonia prevention vaccines. The use of a nurse-driven
protocol provided clinical significance that answered the PICOT question since its use
contributes to the reduction of the public health concern related to morbidity and mortality of
VPD such as pneumococcal infections among high-risk and under-immunized individuals.
Program Analysis and Evaluation Plan
After careful evaluation of the literature evidence, nurse-driven protocols are considered
an evidence-based intervention with effective program outcomes to increase vaccination rates
(Capitano, 2018). Nurse-driven protocols utilized in adult vaccine programs expands access to
vaccines (NVAC, 2014). Patients can easily schedule an appointment with a nurse for an
immunization assessment without a required primary care physician order. Adding nurse
schedules to clinical practices expands access to vaccines outside of the doctor visit norm.
Applicability of vaccine protocols extends to other health settings like pharmacies, urgent cares,
specialty, and retail clinics. The utilization of nurse-driven protocols or vaccine standing orders
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is highly advised by governmental and independent health agencies as an effective tactic to
improve vaccine administration practices and improve workflows. Inclusion of best practices in
the development of an adult vaccine program (AVP) along with a competency-based orientation
(CBO) toolkit, will guide nurses in ambulatory settings to improve vaccination uptake and
increase their awareness on best vaccine practices (Guide to Community Preventive Services
Task Force, 2016).
Applicability and Implementation Strategy
The CBO toolkit will be utilized as a training tool in an internal medicine ambulatory
setting by nursing staff. A registered nurse will be assigned as vaccine champion and program
facilitator to support existing staff and new hires when working in the nurse clinic. Review of the
toolkit will be part of the orientation phase for onboarding nurses and annual review is
recommended to assess competency. Formative assessment can be attained through monthly
chart audits on staff performance and impact of vaccine program, see (Appendix D). This
strategy will provide practice feedback, reinforcement on best practice, and corrective actions as
needed. Summative assessment can be evaluated with an annual competency review of the nurse
workflow and quiz of the AVP, (Appendix E). The AVP will include the National Vaccine
Advisory Committee tool that integrates Standards for Adult Immunization Practice. A
recommendation to create a template for nurse visits will be proposed to include these four
standards to improve the assessment of immunization status for the nurse workflow, (see
Appendix F). Review of the vaccine program is located in (Appendix G).
The program will increase demand for vaccination by sending reminders when vaccines
are due or recall of missed vaccine appointments with support of electronic health system
support tools. The adult vaccine program will decrease the number of missed opportunities due
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to missing provider orders and the utilization of a nurse-driven protocol to identify eligible
adults. Workflow improvements can enhance immunization programs and decrease the
probability of VPD in high-risk groups.
Selection of Best Practices
The inclusion of best practices for this adult vaccine program was synthesized by the
review of three health organizations that recommended vaccine guidelines and offered evidencebased interventions focused on improving vaccine practices and optimizing preventive health
measures that mitigate vaccine preventable diseases like pneumonia, see summary in Table 3.
The CDC program evaluation model offered a guide to appraise each entity and toolkits
described in this project, highlighting key stakeholders (nurse, manager, patients, medical
director, CNO) and their association with program goals and objectives, and linking metrics that
justify recommendations. Agencies such as the CDC, NVAC, and CPSTF, are aligned with their
recommendations to improve vaccination rates, improve the health of at-risk populations,
mitigate missed opportunities to inoculate, integrate vaccination information systems,
recommendation of new vaccine policies, and enhance performance feedback (CDC, 2019;
Kobayashi, 2022; NVAC, 2014). These organizations support best immunization practices for all
healthcare professionals in different clinical settings when considering vaccine initiatives. The
toolkits identified that follow the CDC program evaluation model are the Kaiser Permanente
Covid19 vaccine equity toolkit and the Adults Immunization Toolkit for Clinicians.
For this vaccine program evaluation, the use of nurse-driven vaccine protocols is strongly
recommended by two of the reviewed organizations, ACIP and NVAC. Tools to support nursedriven protocols are found in these websites which provide a guide for implementation and
resources that highlight the impact of protocols to change policy (see Table 4). The CDC
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represents a reputable and recognized entity for vaccine guidelines and recommendations.
Additionally, the National Vaccine Advisory Committee guides the recommendations published
by the CDC when following best practices for the adult pneumococcal vaccine. Both agencies set
the standards for vaccine administration and guidelines to follow when health professionals
advise patients. All three organizations follow most of the CDC program evaluation model’s
standards and steps as depicted in Table 3. They clearly identify similar key stakeholders,
provide a succinct program description with defined goals, an outline of focused design to
increase vaccine rate and practices, summary of evidence-based interventions that support best
vaccine practices, and strong recommendations to stakeholders. The toolkits reveal relevant
metrics to improve vaccine practices and offer strong interventions underutilized during nurse
visits. For the proposed AVP and CBO toolkit, this framework provides a broader understanding
of key elements vital to its formulation. The logic model presents a flow of multiple actions
required to implement the program and improve current workflows (see Table 5). Anticipated
budgetary expense for vaccine expansion over an eight-week timeline is outlined in Table 6.
Expenses entail purchase of vaccines by the health institution with an approximate amount of
$2,000 per month. Staffing will not create an additional expense since an RN and LVN are
already part of the clinical site team.
Program Evaluation Discussion and Recommendations
Adult vaccine programs with integrated nurse-driven vaccine protocols, support clinical
workflows in ambulatory settings by expanding access to preventive services and reducing the
rate of vaccine preventable disease among adults (Harris, 2021). After the appraisal of the
toolkits and adult immunization programs, findings revealed that the use of more than one
evidence-based intervention are more effective at increasing immunization rates than single-led
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interventions. Practices with nurse-driven vaccine protocols offer vaccinators autonomy to
assess, recommend, and inoculate under-immunized adults in a variety of settings. Additionally,
ensuring services are delivered in an equitable form by including interpreting services for nonEnglish speakers, extended hours of nurse schedule to accommodate working families, and
access to schedule appointments by phone, patient portal, and on a walk-in basis.
To evaluate staff performance on the utilization of nurse-driven vaccine protocol policy,
the nurse champion will perform monthly chart audits with the use of an audit tool (see
Appendix D). This tool will support data collection on nurse performing assessment, whether the
immunization history was reviewed, and if the patient was immunized or not. To assess
knowledge retention, every vaccine administrator will complete an annual assessment by
completing a four-question quiz. Opportunity to remediate will be available after nurse meets
with nurse champion to review topic. To sustain the adult vaccine program with best practices
identified, the nurse champion and/or nurse preceptor will use the Immunization Action
Coalition (IAC) checklist to evaluate the workflow in place. This tool will help identify areas for
improvement and a plan of action to support the vaccinator. With the support of the analytics or
informatics team, weekly vaccine rates will be gathered by running reports specific to the clinical
site and shared during staff meetings and/or huddles meets. Vaccine rates can be posted on the
daily engagement board to provide a visual aid and feedback on success or challenges of the
program.
Recommendation to survey new hires two months post mentorship program is ideal to
identify any barriers or suggestions about the program. This will allow them the opportunity to
voice any concerns regarding the orientation process and experience with preceptor. Potential
limitations to this adult vaccine program are the impact of the Covid19 pandemic on the nurse
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clinic accessibility due to staffing shortages and stocking of vaccines due to shipment delays.
Acceptance of new practice by current staff nurses is a concern since it poses risk of scrutiny of
their current practice. Colmegna et al. (2021) identified personal beliefs and vaccine experiences
as barriers to increase immunization rates. Implementation of an adult pneumococcal vaccine
program that integrates best practices (nurse-driven protocol policy, patient reminder system, and
standardized workflow) recommended by this project, will improve vaccine rates among adults
65 years and older. It will also provide a guide to help orient new hires in ambulatory settings
coordinating preventive health services like vaccines. The tools gathered will support nurse
champions and mentors with the orientation process and performance evaluation.
The developed CBO toolkit (Appendix H) is designed to help orient new nurse hires
execute proper vaccine needs assessment of an electronic health record, decrease missed
opportunities, advise adults on the pneumococcal vaccine, and increase pneumococcal vaccine
uptake. This toolkit is intended for an audience of healthcare professionals, nurses, and quality
improvement nurses that seek to enhance immunization practices in their clinical setting. It
outlines glossary of terms, an implementation strategy, key stakeholders involved with the
implementation process, and tools that support nurse instruction and patient engagement
handouts.
This program evaluation has gathered evidenced-based interventions (see Appendix H)
that support the success of an adult pneumococcal vaccine program and development of an
extensive competency-based orientation toolkit. Based on the CDCs program evaluation
framework, this CBO toolkit outlines the benefits of investing resources to engage key
stakeholders (patients, nurses, manager, physicians) with the improvement of immunization
processes to mitigate vaccine preventable diseases, especially among high-risk adults. Clinical
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sites can obtain baseline data with the support of the electronic health system to run reports and
by the utilization of an audit tool and measure the process outcome and vaccine rate post
intervention. Data will reveal current adult pneumococcal vaccine status to serve as a base to
compare numbers post implementation of this CBO toolkit. This toolkit meets criteria described
in the CDCs framework for a successful vaccine program. Collected data can support informed
decision-making for stakeholders to determine the need to stock vaccines that reduce the
likelihood of pneumococcal disease among high-risk adults, increase their quality of life, and
decrease hospital admissions related to community acquired pneumonia. Additionally, the CBO
toolkit is designed to ease new nurse hires orientation process when working immunization
clinics, empower them with resources that support their skill set, and sustain evidence-based
practice in nursing. Limitations of this project is the utilization of nurse-driven protocol policy to
licensed nurses only, excluding medical assistants. Another limitation is the vaccine expense by
smaller private practices with a small adult population aged 65 years and older.

Dissemination Plan

Upon conclusion of this adult vaccine program evaluation and CBO toolkit, findings will
be shared with clinical site members during a general staff meeting with the use of a PowerPoint
presentation as a visual aid with graphs. The use of a PPT can be posted on the ambulatory
services intranet site for reference and easy access. Updating the clinical site team will provide a
deeper insight of the application and utilization of the CBO to improve a staff orientation and
safe preventive health services. A quicker response to the toolkit use can be obtained post
presentation by allowing time for question-and-answer session. At an organizational level, this
health entity holds professional development committee meetings every other month and allows
the opportunity to share findings during one of these scheduled sessions. These sessions can be
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arranged with the support of the assistant nursing director and committee members.
Dissemination at this level, reaches other ambulatory nurse leaders and potential for them
to adopt the findings. Additionally, staff members of the population health services and
education department working directly with meeting immunization metrics and new employee
orientation, can appreciate the application and utilization of the toolkit and advantage of an adult
vaccine protocol. At a national level, an abstract of the results will be submitted for a poster
presentation at the annual nursing conference hosted by the National Association of Hispanic
Nurses. This manuscript will be published on the University of Saint Augustine for Health
Sciences institutional scholarship and open access repository (SOAR). A written manuscript will
be submitted to the Journal of American Academy of Ambulatory Care Nursing and Hispanic
Health Care International Journal for publication consideration.
Conclusion
The purpose of this adult vaccine program evaluation and development of a competencybased orientation toolkit was to improve the quality of health among high-risk adults from
preventable vaccine diseases by increasing vaccine uptake and support the delivery of safe
injection practices in ambulatory settings by nurses. Implementation of an adult vaccine protocol
in ambulatory settings, as proposed by the Immunization Action Coalition, enhanced access to
preventive services and adds nurse autonomy to inoculate adults. Deaths correlated to pneumonia
disease among the geriatric population remain a public health concern related to underimmunized adults. Integrating a nurse-driven protocol to adult vaccine programs has a direct
correlation with increase pneumococcal vaccines rates among high-risk populations. An
extensive CBO toolkit offers new nurse hires and nurses transitioning to ambulatory settings a
broader understanding of safe injection practices and vaccine indications when managing a nurse
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schedule. It offers autonomy and a higher level of competency when performing immunization
assessments. Further quality improvement projects need to assess the association of competency
in licensed vocational nurses and toolkit utilization to expand delivery of services by other
licensed staff members.
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Table 1

Evidence Table
Author/Year

Study Design

Level of Evidence

Grade of
Evidence

Bond (2009)

Cross sectional study

II

B

Capitano (2018)

Cross Sectional study

III

B

Gamble (2008)

Quasi-experimental

II

B

Goebel (2005)

Meta-Analysis of 81 CT

II

A

Nonexperimental

III

B

II

B

II

A

II

A

III

A

II

B

Kim et al. (2014)

descriptive study
Lau (2012)

Systematic Review/MetaAnalysis of RCT and Non
RCT

Loskutova (2020)

Quasi-experimental/non
RCT

Smith (2011)

Quasi-experimental/Control
Trial

Tan (2020)

Nonexperimental
descriptive study

Trick (2009)

Clinical Control Trial
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Table 2
Synthesis Table

Author/Year Intervention
Favored
Loskutova,
Multimodal
2020
Intervention:
Standing
Order,
reminder, &
visual aid.

Setting/Population P value

Goebel, 2005 Verbal or
written Flu
vaccine
standing
order.
Lau, 2012
Multimodal
Intervention:
Team change:
nurse order;
pharmacist
order, ER tech
order

Primary setting.
Elderly: 65 yrs or
older

Trick, 2009

Tertiary setting.
Adults >= 18 yrs

Bond, 2009

Multimodal
intervention:
Written policy
for MD
w/CDS was
favored over
the RN
standing order
with clinical
decision
support
(CDS) tool.
Standing
order protocol

Large Primary
setting.
Adults: >= 18 yrs

Primary setting.
Adults and highrisk adults.

Primary setting
Adults

Intervention
P < 0.0001
(increased
by 18.4%)

I: intervention.
C: comparison
Comparison Best Outcome
Control:
MD
P <0.0001 reminder
(Increased system
by 16.7
%)

I: 81.4%
pneumococcal
vaccine rate
uptake.
C:72.7 %
pneumococcal
vaccine rate
uptake.
Standard
I: 576 (63%) of
Care
the 912 were
inoculated.
C: only 38 %
were vaccinated.
Interventions associated Standard
Team changes
w/improvements: Odd
care: MD
were more
ratio (OR) = 1.61, 95 % reminders;
effective to
CI.
patient
improve
Flu: OR =1.46, 95% CI. outreach;
pneumococcal
Pneumococcal: OR 2.01; financial
and influenza
95% CI
incentives;
vaccination rates
case
in association
management. with personal
contact. SOP and
face to face
interaction.
Patient incentives
also proved
effective.
MD intervention
Standard
RN order with
effectiveness: 12%.
care.
CDS proved
RN intervention
ineffective.
effectiveness: 6%.
MD with CDS
proved more
effective.

Intervention:
Flu vaccine rate 18%.

MD order

PPV & Hep B
vaccine rates
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or facility
wide order
proved more
effective than
MD order
alone.

Hep B vaccine rate 22%.
Pneumococcal rate 34%

were greater with
SOP or FWO and
preprinted orders.

Smith, 2011

Multimodal
intervention:
Nursing
screening
tool, nursing
education,
electronic
vaccine order
protocol,
automated
dispensing
cabinets and
vaccine
tracking
system.

Tertiary setting: 2
internal medicine
units.
Adults 65 yrs and
older.

Multimodal intervention
vs pre-implementation:
74.2% vs 19.1 %,
P < 0.001.

MD order

Tan, 2020

Multimodal
intervention:
Standing
Order
Protocol,
electronic
medical
record,
vaccine
champion,
staff
education,
walk in
services,
patient
reminders,
and vaccine
tracking
system.

Primary setting.
Five primary care
clinics.
Four were primary
care and one
OBGYN.
Adults >= 18 yrs.

Multimodal
intervention.
Pneumococcal vaccine
rate increased after
intervention in
comparison to baseline
(24% to 60%).

MD order

Flu vaccine rate
increased with
MD order and
SOP but not
significant.
I: 74.2 %
inoculated
eligible patients
of 300
participants.
C: 19.1 %
inoculated preintervention
implementation.
A multimodal
approach was
associated with
improved
pneumococcal
vaccination rates.
Protocol changes
easily
implemented.
Process can be
adapted in other
settings.
All 5 sites
reported increase
in vaccination
rates.
Implementation
of SOPs
provided
successful
integration of
adult
immunizations
into office
routines.
A multimodal
approach is more
successful than a
single
intervention at
increasing
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vaccine rates
(17% vs 4%).
Capitano,
2018

Pneumococcal
immunization
protocols
(PIP).
Pharmacist
driven
protocol.

Primary/tertiary
setting.
67 clinical
pharmacists were
surveyed from 50
states.
n=56 inpatient
sites.
n=38 outpatient
sites.

Inpatient sites: 45 (80
%) of 56 used written
standard order protocols.
Outpatient sites: 19
(50%) of 38 reported use
of a written PIP.
Only 36% (34/94) of
clinical sites have
adopted PIP following
ACIP 2012
recommendations.

MD order
Electronic
physician
reminders.

Successful
maintenance
programs.
Champions
lacked.
Poor knowledge
of national
immunization
recommendations
by staff.
Computerized
standing orders
was most
effective.
Physicians to
recommend
inoculation
promotes vaccine
uptake.

Computerized standing
orders vs electronic
physician reminders
(51% vs 31 %, P<
0.001)

Gamble,
2008

Standing
order
immunization
policy.
Immunization
flow sheets.

Three primary care
setting.
Adults > = 65 yrs

Increase in
immunization rate but
not statistically
significant.
Hypothesized goal: 15%
Pneumococcal baseline:
35% of vaccine uptake
pre-implementation.
Post intervention: 13%.
Use of flow sheets were
inconsistent.

Usual
practice: no
SOIP and
flow sheet.

Standing order
immunization
policy found to
be most effective
strategy for
increasing
immunization
rate.
Staff behavior
must change for
intervention to be
successful.
Flow sheets
support success
of SOIP.
Monitoring
process is critical
for an effective
newly
implemented
policy.

Kim et al,
2014

Multimodal
and single
intervention.
Physician
computerized
reminders,
checklists,

Tertiary setting.
Adults >= 65 yrs.
Review of 35
studies.

Twenty one of 35
studies used SOP in
tertiary settings.

Physician
reminders.
Preprinted
orders.

Standing orders
had higher
statistically
significance 78%
in comparison to
other
interventions.
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and standing
orders.
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Provider
reminders: 74%.
Pre-printed
orders 42%.
Multimodal
interventions
were most
successful.
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Table 3
Summary Table
CDC
Evaluation
Program

Advisory Committee
on Immunization
Practices (ACIP)

National Vaccine
Advisory
Committee (NVAC)

U.S. Community
Preventive
Services Task
Force (CPSTF)

1. Engage
Stakeholders

• Centers for Disease
Control
• Clinicians
• Health Organizations

• Healthcare
Professionals
• Vaccinators
• Non-vaccinators
• Public health
professionals
• Committee Aims:
Recommend tactics
to optimize
preventive measures
that lead to infectious
diseases through
vaccine development
and strategies to
prevent adverse
effects.
• Program goals and
objectives outlined:
studies and advises
strategies to
encourage vaccine
stock in a safe and
effective manner;
recommends
research findings that
enhance the safety
and efficacy of
vaccines, and adviser
to public health
officials that
streamline service.
• Organizational vision:
The U.S> will be a
place where VPD are
eliminated through
safe and effective
vaccination over the
lifespan.
• Organizational goals:
The Vaccine Plan
establishes 5 goals
w/objectives: G1-

• Healthcare
Professionals
• Department of
Public health and
Human Services

2. Describe the • Program Aim: Advice
Program
and guide on current
pneumococcal vaccine
recommendations with
age-appropriate
timelines, interval,
number of doses,
precautions, and
contraindications.
• Describes goals and
objectives.
• Program describes
specific metrics collected
for analysis (PPSV23 and
PCV13).
• Organization provides
overview of current
vaccine practice and
guidelines.
• Identifies effect of
program: Impact on
public health practice
simplifies guideline to
improve clinician
recommendation rate
and decrease confusion.
• Identifies barriers to
vaccine recommendation
(confusing guidelines).
• Outlines recent findings
in RCT for new
recommendations: PCV15
and PCV20 safety and
immunogenicity in
comparison to previous
practice.

• Organizational Aim:
offers evidencebased interventions
on many health
topics to improve
health, disease
preventive tactics,
and health policies to
improve delivery of
services.
• Tools: Vaccination
Program focused on
health care systembased interventions
implemented in
combination.
• Metrics: provider
performance, vaccine
access, utilization of
standing order
protocol, vaccine
rate among adults,
and missed
opportunities.
• Program Effects:
improve patient
health outreach
through reminder
systems, increase
vaccine rates,
increase client-based
education on
immunizations,
increase access to
vaccinations, reduce
out-of-pocket
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• Outline offers future
research and monitoring
priorities: continue to
assess safety of new
recommended vaccines,
monitor impact of new
policy implementation,
assess
postimplementation
vaccine effectiveness and
update vaccine guidelines
as needed.
• Acknowledgements:
ACIP.
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Foster innovation
expense, integrate
by supporting the
standing order, and
development of
measure vaccinator
innovative, safe, and
performance
effective vaccines to
(benchmarks).
prevent ID of PH
• Analytical
significance; support
framework:
the development and
Findings of EB
uptake of
interventions
technologies to
gathered by
improve vaccine
systematic review of
storage, distributions, most effective
and delivery
outcome.
mechanisms. G2• Identifies problem:
Maintain the highest
Highlights gaps in
possible levels of
immunization
vaccine safety by
practices.
Minimize preventable
vaccine related
adverse events;
improve timely
detection and
assessment of vaccine
safety signaled to
inform PH policy and
clinical practice;
increase awareness,
understanding, and
usability of the
vaccine safety
system. G3- Increase
knowledge of and
confidence in
routinely
recommended
vaccines. G4Increase access to
and use of vaccines in
a variety of settings.
G5- Protect the
health of the nation
by supporting global
immunization efforts
by supporting
research.
• Tools: Standards for
Adult Immunization
Practice.
• Metrics: vaccine
access and use by
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3. Focus
Evaluation
Design

identified population.
Staff utilization of
standard practice
every time to
mitigate missed
opportunities.
• Program effect:
integration of
vaccines to various
clinical settings to
improve access,
promote vaccine
safety and prevention
and reporting of
adverse effects.
Mitigate VPD.
Improve clinical
practice. Increase
awareness of vaccine
utilization. Protect
the nation’s health.
Support global
immunization.
• Identifies problem:
under immunized
patients, clinical staff
has poor
understanding of
immunizations for
adults, underrecommended
vaccines by clinicians,
and missed
opportunities.
• Organization provides
• Program aims to
•
evidence-based findings
increase access to
to guide healthcare
vaccine uptake at
professionals on
a variety of clinical
recommending
settings by
pneumococcal vaccines
providing a tool
based on their safety and
that improves
antibody response with
clinical practice.
simplified guidelines to
• Tool: Practice
mitigate the prevalence
Standards aims to
of pneumonia among
integrate a
high-risk adults.
workflow to
• Organization provides
clinical practice
cost-effectiveness of new
that identifies
policy compared to
gaps in health

39

Program aims to
improve
immunization
practices in a
range of clinical
settings and client
populations with
the use of
strongest
evidence-based
interventions
found by
performing a
systematic review.
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existing
recommendations.
• New policy aims reduce
pneumococcal disease
prevalence in adults aged
65 years and older and in
those 19-64 years with
high-risk conditions.
• Ongoing monitoring of
new recommendation
practices, vaccine
effectiveness, and update
guidelines as needed.

•

•

4. Gather
Credible
Evidence

• Provides summary of
public health impact on
new policy to reduce
pneumococcal disease
prevalence in adults aged
65 years and older and in
those 19-64 years with
high-risk conditions
based on
immunogenicity and
safety in RCT.

•

maintenance and
•
strongly
recommend
vaccines if
stocked, otherwise
recommends
•
referring patients
to settings that
inoculate. Once
identified, tool
advises to
immunize and
document in EHR
or state’s
immunization
registry.
Tool
recommendations:
follow up with
patients when
referred to other
settings and
update health
system.
Tool recommends
clinicians to stay
informed.

Program aims to
increase
vaccinations rates
within a targeted
population.
Multi-intervention
approach revealed
highest effect on
vaccination rates.

•

Program only
recommends
interventions that
yield best
evidence-based
outcome.
Program
recommendations
are based on
systematic
reviews on most
effective
interventions to
improve
vaccination rates.
Indicators:
vaccine rates,
performance
feedback, use of
standing order
protocol, decrease

Standards for
Adult
Immunization
Practice tool is
considered an EB
intervention that
proves effective to
increase vaccine
uptake, improve
vaccine access,
mitigate myths or
barriers that
prevent
immunization,
minimize missed
opportunities to
vaccinate, and
increase access to
immunization
status by
participating in

•

•
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•

5. Justify
Conclusions

•

•

•

•

•

Recommendation to
•
clinicians is the review
of package insert prior
to administration of
new vaccine policy.
Indicates reporting of
adverse effects after
inoculation to VAER
system to ongoing
monitoring of vaccine
safety.
Revision/simplification
•
of guidelines enhance
vaccine
recommendation by
clinicians.
New policy
recommendation
reveals comparable
outcomes against
•
existing guidelines.
Practice guidelines
help support vaccine
uptake among highrisk adults.
•

•

state’s
immunization
registry.
Indicators:
vaccine uptake
rate, percentage of
missed
opportunities.
Organization
provides tools to
integrate best
immunization
practices in health
settings that
vaccinate and in
those that do not
but can identify
population in need
and refer them to
ones that do.
Strongly
recommends safe
injection practices
by staying
informed on
recommended
vaccines for adults
through CDC site.
Organization
encourages
integration of
protocols and
policies that
vaccine status is
routinely assess.
Organization
encourages
patient vaccine
reminders.
Website offers
multiple tools to
support patient
and staff
education,

out-of-pocket
expense, increase
access to
vaccination
services, and
vaccination
outreach.
•

•
•

•

Evidence-based
interventions
supported higher
vaccination rates.
Program is
applicable in an
array of settings.
Program
recommends a
multi-modal or
combination use
of interventions
versus single
intervention
approach to
maximize impact
of project
outcome.
Recommends
strongest
standards of
practice based on
research.
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6. Ensure Use
and Share
Lessons

•

•

•

•
•

Design (evaluation
design): Informative.
Aims to deliver new
evidence for clinical
practice.
Preparation (planning
steps for use of
evaluation findings):
Makes
recommendations of
cost-effective practice,
encourages use of safe
vaccines, and
encourages reporting
of any adverse effects.
Feedback: Reports
continuous monitoring
of new vaccines.
Provides email address
to communicate
concerns. None clearly
identified.
Follow-up (support to
users): non identified.
Dissemination:
Findings delivered in
the Morbidity and
Mortality Weekly
Report on CDC
website; available to
health professionals.

•

•

Design (evaluation
design):
Informative.
Evidence-based
strategies to
reduce missed
opportunities and
improve vaccine
rates. Design is in
alignment with
organizational
vision and goals
and governmental
organizations
focused in VPD
and improving
immunization
practices.
Preparation
(planning steps
for use of
evaluation
findings): Clearly
identifies barriers
and provides
recommendations
to overcome
barriers with use
of tool: Standards
for Adult
Immunization
Practices.
Integrating
integration of
standing orders to
authorize nurses,
pharmacists, and
other ancillary
staff to expand
access to vaccine
administration.
Add patient
reminders when
vaccines are due.
Application of
immunization
information
systems to
support
assessment of

•

•

•

•
•

Design
(evaluation
design): Outlines
evidence-based
interventions in
alignment to
program goal:
increase demand
for vaccinations
increase access to
vaccination sites,
utilization of
immunization
information
systems to
integrate clinical
support tools,
standing orders,
and assess
performance
feedback.
Preparation
(planning steps
for use of
evaluation
findings):
Provides
strategies to
integrate each
intervention and
evidence that
supports
recommendations.
Feedback:
utilization of
information
systems to trace
and provide
performance
feedback.
Follow-up: non
identified.
Dissemination:
tool easily
accessed on
organization
website by
healthcare
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•

•

•

vaccines,
reminders, and
recall
interventions, as
well as provider
assessment and
feedback.
Feedback:
recommends chart
audits, patient
surveys, and
electronic systems
for tracking.
Follow-up:
integrate a policy
that includes
vaccine
champions. Design
of tool is user
friendly and
applicable to
integrate in
notes/templates.
Dissemination:
Tool found on
organization
website for easy
access and
replication at
various clinical
sites.

professionals and
public.
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Table 4
Summary of Toolkits
CDC
Evaluation
Program

Kaiser Permanente
Covid19 vaccineequity Toolkit.
Covid-19 Vaccine
Equity Toolkit

1. Engage
• At risk population
Stakeholders • Vaccine administrators
• Local agencies
• State agencies
• Other health entities
• Health plans

2. Describe the
Program

Program
alignment
with CDC
program
evaluation
framework.
• Clearly
identifies
stakeholders
in each tool
and role.
• KP: Identifies
gap in access
to covid19
vaccine within
high-risk
population.
• Toolkit
identifies the
need to
improve
vaccine rate
among adults.

• KP framework for
equitable
administration of
Covid19 vaccines.
• Includes a
• Metrics measured:
statement of
vaccine equity and
need.
impact.
• Describes
• Toolkit contains
goals and
strategies to enhance
objectives.
vaccine administration • Program
approach.
describes
• External links to leading
specific
practices and resources
metrics
collected for
analysis.
• Identifies
purpose
toolkit.

Adults Immunization
Toolkit for Clinicians
Adult Immz Toolkit for
Clinicians
•
•
•
•

Adults
Clinicians
Health care centers
Collaborating agencies: CDC
and Immunization Action
Coalition (IAC).

• Clearly outlines
components of the toolkit in
its table of contents.
• Provides an overview of the
problem, barriers for
vaccine uptake, and
purpose of the toolkit to
improve vaccine rates
among adults.
• Toolkit aims to improve
vaccine rated by providing
resources and
recommendations for
clinicians (statement of
need).
• Toolkit components focus
on increasing vaccine
awareness, integrating
safety practices, utilization

PROGRAM EVALUATION CBO TOOLKIT

3. Focus
Evaluation
Design

• Meet or increase
vaccination rates within
communities in the
25% most vulnerable
geographies.
• Support equitable
distribution and
administration of
vaccines beyond
geographic need
(inclusiveness)
• Metrics: age, high-risk
designation,
race/ethnicity,
geography, and
health/equity indices.
• Standards of
Performance: Social
vulnerability index
(SVI), Neighborhood
Deprivation Index
(NDI), and others
outlined.
• An agreement is
identified at the end of
the toolkit (simple
memorandum of
understanding).

45
of audit tools, and practice
change model (AWV and
standing orders).
• Quality metrics identified:
Merit-based Incentive
payment system (MIPS) and
Minimum Data Set (MDS),
flu and pneumococcal
vaccine rate.
• Tool: 10 Steps to
Implementing Standing
Orders, outlines the process
to integrate into practice,
resources needed, and
stakeholders.
• Identifies the purpose of
the tool.
• References organizations
with standards of best
• Clearly
practice with delivery of
identifies
vaccines.
they purpose
• Toolkit output measures
of the tool.
vaccine rate for the
• Clearly
PPSV23 and PCV13. Offers
identifies
a tipsheet to guide coding
outcomes
practices and vaccine
measured by
criteria.
each tool
•
Toolkit outcome aims to
included.
improve the health of
• Identifies
adults and decrease
different
incidence of disease with
uses of data.
preventive health services
like vaccines.
• Recommends use of MDS
and MIPS to gain data
collection for ongoing of
program improvement.
Describes each metric and
source (EHR, registry,
CMS web, claims).
• Toolkit is aligned with
standards of safety
practices and vaccine
schedules by the CDC.
• Improve practice model
to decrease missed
opportunities.
• Update program with CDC
guidelines as needed.
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• Improve access to vaccine
services with utilization of
standing orders.
• Tools promote process
improvement to meet
organizational goals by
improving vaccine rates
4. Gather
Credible
Evidence

Measured data includes:
• Age categories to meet
vaccination criteria.
• Vaccination rates
within high-risk groups
defined by the CDC.
• Racial and ethnic
vaccination rates.
• Demographics
• Program aligns with
state-approved indices
as a best practice to
integrate and capture
degree of vulnerability
and deprivation in
specific geographic
areas.

5. Justify
Conclusions

• Recommendation for
each state to align to the
applicable stateapproved index.
• Recommends
• Tools for equity
alignment of
application is
local state
situational to improve
index or
vaccine equity.
contact
• Tool can support QI
information to
projects or enhance
monitor
outreach.
indicators.
• Tool can support
• Tools
overall vaccine uptake
highlighted are
among identified
aligned with
vulnerable populations.
indicators

• These
indicators
are
appropriate
to the design
of the
program and
aligned with
the purpose
of the indices
utilized.
• Criteria for
indicator is
clear and
provides
purpose.
Answers why
it was
selected.
• Sources of
evidence are
outlined.

• Recommends best
standard of practice to
integrate adult
vaccinations as part of the
workflow to improve staff
performance.
• Measured indicators:
vaccine data (PPSV23 and
PCV13) among adults
provides overview of
program effectiveness.
• Sources of evidence
gathered from electronic
health systems and
immunization registries.
• Utilization of toolkit aims
to improve the overall
health of adults.
• Toolkit offers guidelines to
implement new policies
and practices by
integrating standing
orders to improve
workflows and vaccine
access.
• The toolkit offers
different evidence-based
strategies that improve
vaccine rates among
adults recommended by
state and federal
agencies.
• Toolkit resources offer
strategies to implement
new workflows that
improve immunization
practices.
• Toolkit resources offer
tactics to improve vaccine
administration safety and
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being
• Case studies that reveal
measured.
the usefulness of equity
tools to enable access to • Indicators
the Covid19 vaccine.
selected will
help identify
• Strategies identify help
themes in
support the vaccine
results.
uptake and enhance
equity.
• Tools help
identify need
• Tool with Evidenceto allocate
Based strategies for
vaccine
increased community
resources.
trust for Covid
vaccination.
• Case studies
reveal
utilization in
different
populations.
• EB toolkit
reveals tactics
to improve
vaccine uptake
based on
indicators
(improves
patient
outcomes).

•

•

•

•

•

6. Ensure Use
and Share
Lessons

• Equity tool design is
applicable to
organizations focused on • Tools identify
vulnerable populations
stakeholders
for vaccine access.
involved with
• Additional tools are
program.
guides to identify and
• Tools support
communicate logistics
transparency
and operation of
of program.
vaccination equity
• Program
facilitators.
provides

infection control
practices.
Toolkit resources offer
best practices found in
scholarly articles to
improve vaccine rates.
The utilization of this
toolkit offers visual aids
to support different
learning and teaching
styles when educating
key stakeholders.
The toolkit makes strong
recommendation of
interventions that offer
strong evidence to
improve immunization
uptake in adults and
integrate tactics that
identify eligible adults for
inoculation.
Recommends promotion
of vaccine confidence:
wearing stickers, buttons,
and referencing
organizations when
messages/reminders are
sent.
Toolkit offers an audit
tool to track vaccine
uptake with basic
information: client
identifier, vaccine
administration date, and
met or not criteria to
inoculate.

• Toolkit design includes
useful and credible
resources that support
vaccine program
enhancements to improve
immunization rates among
adults.
• Toolkit offers strong
recommendations to
enhance vaccine awareness
with use of posters in exam
rooms.
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clears
• The design of the
understanding
program provides
of utilization
multiple tools for health
to identify a
entities to tailor
community
equitable vaccine
need and close
administration based on
the gap.
physical, operational,
education and cultural
• The design of
enablers.
the program
categorizes
• Case studies provide
organizational
leading practices on the
areas of
utilization of the tools
opportunity to
facilitate vaccine equity.
enhance
vaccine
programs.
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• Toolkit offers a Covid19
status communication
toolkit, but none for
pneumococcal vaccines.
• Toolkit offers strategy to
provide equitable vaccine
access to those unable to
visit a health center like
mobile vaccination teams.
Recommends extension of
nurse schedule hours to
accommodate working
adults, offer interpretation
services, and access to
schedule appointments in
various forms (online
scheduling, face-to-face,
and telephone).
• Toolkit includes link (see
link above) to online
continuing education
resources with vaccine
focused courses.
Contributes to professional
development of team.
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Table 5
Adult Pneumococcal Vaccine Program Logic Model

INPUTS
• Vaccine cost
• Full time
RN/LVN
• Educational
materials
(printed or web)
• Vaccines
• Vaccine supplies
(syringes,
bandaid, alcohol
swabs, needles).
• Vaccine
scanners
• Policy and
procedures.
• Expand
availability of
nurse schedule
• Interpreting
services
• EPIC electronic
health system.

OUTPUTS
• PreVisit
planning
• Screen for
vaccine
eligibility
• Train staff on
AVP
• Develop a
toolkit.
• Assess
utilization of
toolkit.
• Administer
pneumoccocal
vaccine.
• Assess vaccine
rate.
• Utilization of
interpretation
services using
MARTI device.
• Time alloted to
conduct nurse
visit.
• Integrate other
team members
to identify
eligible patients
for vaccine.
• Schedule
patients for
same day nurse
visit

SHORT TERM
GOALS
• Increase access
to preventive
health services.
• Improve nurses
comfort to
recommend
vaccine based
on CDC
guidelines.
• Increase vacine
awareness.
• Change attitude
towards
immunizations.
• Increase
awareness of
resources and
tools (CDC and
health systmem
tools).
• Update
guidelines as
needed

Intermediate
Outcomes
• Ongoing data
collection
• Obtain vaccine
administrators'
feedback on
program.
• Promote safe
injection
practices
• Decrease missed
opportunities.

LONG TERM GOAL
• Improve health
of high-risk
population
• Improve
organizational
goal on vaccine
uptake
• Decrease
hospitalizations
related to
pneumonia
disease among
vaccinated
population.
• Reduce gap in
access to
preventive
health services
among the
geriatric
population.
• Improve quality
of life for high
risk adults at
risk for
pneumococcal
disease.
• Annual
competency
assessment.
• Revison of
prorgram.
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Table 6
Budget for 8-week Project.
EXPENSES
Direct
Salary and benefits:
No additional expense.
Clinical staff will support
project.
Supplies: $300.00/month
Vaccines: $2,000.00/month
Services: $0.00 copay for
nurse visit.
Statistician: 0.00
Indirect
Overhead 0.00

REVENUE
Billing: Already part of the workflow.
Grants. 0.00

Total Expenses: $4,600.00
Net Balance

Total Revenue: unknown.

Institutional budget support. 100%.
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Figure 1

PRISMA Flow Diagram

Screening

Identification

Identification of studies via databases and registers

Records identified from*:
Databases (n =5)
Registers (n = 0)

Records screened
(n = 100)

Records excluded**
(n =50)

Reports sought for retrieval
(n = 50)

Reports not retrieved
(n =0)

Reports assessed for eligibility
(n = 20)

Included

Records removed before
screening:
Duplicate records removed
(n = 10)
Records marked as ineligible
by automation tools (n =20)
Records removed for other
reasons (n =30)

Reports excluded:
Reason 1 (n =10)
Reason 2 (n = 10)
Reason 3 (n =10)
etc.

Studies included in review
(n =10)
Reports of included studies
(n =10)

Note. Prisma flow chart diagram from “Preferred Reporting Items for Systematic Reviews and Metaanalyses: The PRISMA Statement,” by D. Moher, A. Liberati, J. Tetzlaff, & D. G. Altman, 2009,
Annals of Internal Medicine, 151(4), p. 267 (http://dx.doi.org/10.7326/0003-4819-151-4-20090818000135). Copyright 2009 by The American College of Physicians.
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Figure 2
Adult Immunizations Toolkit for Clinicians
Visit Adult Immunizations Toolkit for Clinicians to access full document.

Adult Immunizations
Toolkit for Clinicians

This material was prepared by Quality Insights, the Medicare Quality Innovation Network-Quality
Improvement Organization for West Virginia and Pennsylvania under contract with the Centers for
Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services.
The contents presented do not necessarily reflect CMS policy. Publication number 12SOW-QI-CC040921

Table of Contents
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Figure 3
Kaiser Permanente Covid-19 Vaccine Equity Toolkit
Visit KP Covod-19 Vaccine Equity Toolkit to access full document.

Agreement: By accessing, using or implementing this document (the “Content”) you understand and agree to the following: 1)
the Content is provided for general informational purposes only, 2) you must exercise independent professional judgment and
make decisions based upon your particular situation, 3) due to rapidly evolving information related to the subject matter of the
Content, the provider of this content takes no responsibility or assume any legal liability for the accuracy of the information or for
the manner in which any person who references them may apply them to any particular person, 4) the Content is not intended as
medical advice, or as a substitute for the medical advice of a physician, 5) you assume all liability and responsibility for the
access, use and implementation of the Content, and 6) the Content may be, in whole or in part, copyrighted material and the
copyright holder retains all rights, title and interest (including intellectual property rights) in and to the Content.
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Appendix A
Summary of Primary Research Evidence
Intervention
Design, Level

Sample

Comparison

Citation
Quality Grade

Loskutova, Quasi2020
experimental/non
RCT
Grade: A
Level: I

Sample size

Large Multispecialty
healthcare
organizations.
Adults.
N= 44
ambulatory
groups

Goebel,
2005

Grade: A
Level II

N= 912 elderly
patients aged 65
years and older.
Ambulatory
setting.

(Definitions
should include
any specific
research tools
used along with
reliability &
validity)

Theoretical
Foundation

Regression
models were
Prospective
used to examine
interventional
the relationship
before and after
between
nonvaccination rates
randomized
and predictor
study.
variable: group
assignment and
baseline
vaccination rates.
20 providers
were in the
comparator
group.
Retrospective
Meta-Analysis
analysis of
of 81 Control
influenza vaccine Trial
usage over 4
years. Verbal or
written standing
order to nurses.

Outcome
Definition

Usefulness
Results
Key Findings

Pneumococcal
rates increased
from 62.8 to 81.4
% in older adults.

Vaccination rates in this study
were comparable to the
national benchmarks early in
the study and exceeded the
national rates in both groups
afterwards.

A standing order
delegated to the
nurse for
identifying
vaccine eligible
patients and
administering the
vaccine, is one

Standing orders accounted for a
significant higher flu
vaccination rate in each study
year.
Most studies were conducted in
tertiary settings.

55

PROGRAM EVALUATION CBO TOOLKIT

Electronic
reminders.
Telephone call
reminders.
Mail reminders.
Education.
Performance
feedback.
Rates of
influenza
vaccination of
912 patients of
two physicians
who used
standing orders
were compared
with vaccination
rates of 884
patients of two
physicians who
did not use
standing orders.
Trick,
2009

Grade: B
Level: II

Inpatient setting.
Internal medicine
patients at
Chicago County
hospital.
Sample
characteristics:
Median age 52
years.
Diverse Sample:
African
Americans.

Clinical Control
Trial that
evaluated 3
influenza
vaccination
strategies.
Physicians and
staff are assigned
to 1 of 3 teams.
Admitted
patients are
sequentially

Clinical
Control Trial

form of
organizational
change that
improved
vaccinations rates.
When data from
all 4 fiscal years
were combined,
physicians who
used standing
orders had a
significantly
higher rate of
influenza
vaccination (63%)
than physicians
who did not
(38%).

The results of this study
provide evidence that standing
orders for the administration of
influenza vaccine are
associated with higher
immunization rates in an
ambulatory setting.

Our best
vaccination rates
occurred when we
presented
physicians with
opt-out orders that
popped up in the
computer record
at the time of
patient discharge;
physicians usually
accepted the
order, and there
was a significant

The success of the standing
order policy depends on the
setting and on the
implementation strategy.

Several previous studies have
shown that standing orders
increase vaccine usage in the
hospital.
In a study in six community
hospitals, standing orders more
effectively increased
vaccination (40.3%) than did
chart reminders (17%) or
physician education (7%).

Written standing order with
electronic reminder for nurses
revealed nonsignificant
increase in rate.
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White.
Hispanic.
Asian.
Females > males.

assigned to a
team.
Team 1 sample:
69.
Team 2 sample:
66.
Team 3 sample
(control team):
69.
Initial Sample
size: 210.
Excluded: 6.
Actual sample
size: 204.
8 febrile patients
were not
vaccinated.
Team One:
standing order
combined with
electronic
prompts to
nurses.
Team Two:
Written policy
combined with
pop-up order to
physicians.
To determine
vaccination rates,
a retrospectively
review of random
sample of patient

increase in the
patient
vaccination rate.
Team 2 yield the
most effective
strategy.
Standing orders
alone proved
ineffective in
large hospitals,
yielding
vaccination rates
of less than 10%.
Hospital settings
have unique
challenges;
physicians focus
on acute issues
rather than
preventive
measures.
Success may be
easier achieved in
smaller settings.
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files after
discharge was
conducted over a
4-month period.

Control team: no
intervention.

Bond,
2009

Tan et al.,
2020

Grade: B
Level: II

Grade: A
Level: III

Of 1,052 dialysis
facilities
considered, 683
returned the
survey, reported
vaccination rates
for 2005 to 2006,
and had 20 or
more patients.

Five sites
participated in
the study and
submitted

Standing-order
policy of the
dialysis facility,
categorized as:
facility-wide
orders and
preprinted
admission orders
for each patient
(chart orders).
Measurement:
Patient
vaccination,
given at or
outside the
center.
Comparison:
physicianspecific orders
and individual
orders.
Study sites
provided
immunization
services in

Cross sectional
study.

Outcome:
Vaccination rates
for influenza,
hepatitis B (full or
partial series),
hepatitis B,
and pneumococcal
vaccine.

Compared with individual
orders, facility-wide standing
orders and chart orders were
not associated with greater
vaccination rates for
influenza but associated with
greater vaccine rates for Hep B
full or partial series and
pneumococcal vaccine.

Existing facilitywide or chartbased order
programs may be
effective in
promoting
vaccination
against hepatitis B
and pneumococcal
disease.

Nonexperimental
descriptive
study.

Sites generally
sustained modest
gains in coverage
rates (4%-8%
increase) after

Standing orders provide a
starting point for improving
adult immunization coverage.
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complete
datasets.

accordance with
ACIP
recommendations
and clinical
standards for
care. Each site
determined the
adult vaccines for
which they
would implement
SOPs.
Site champions
and clinic
personnel
determined their
adult vaccination
SOP
implementation
dates. Baseline
vaccination rates
were calculated
for the year prior
to SOP
implementation.
Vaccination rates
were tracked for
1 year after SOP
implementation.
During the
intervention year,
cumulative
vaccination rates
were calculated
every quarter.
Reports with
comparison data

SOP
implementation,
but greater
success was found
in practices that
used SOPs as a
foundation on
which additional
interventions were
built.
In general, end-ofintervention-year
vaccination rates
were higher than
baseline rates with
a 4%-8% increase
for most vaccines
at most sites.
Sites that
integrated a
program clinical
decision support
into its EMR for
risk-based
recommendations
for pneumococcal
vaccinations
(PCV13 and
PPSV23)
impacted their
rates. The baseline
immunization rate
for PPSV23 highrisk patients was
24%; it increased
to 60%.

Sustaining higher adult
immunization rates needs
intervention beyond standing
order.
Prioritization of adult
immunization is challenging
without incentives.
Better integration of clinic and
state data may increase adult
immunization rates.
Challenges to increasing
coverage rates included
prioritization of acute and
chronic conditions over adult
vaccination, Medicare Part D
reimbursement policies,
electronic medical record issues
related to data reporting and
programming.
The implementation of SOPs
provided critical infrastructure
and successfully integrated
adult immunization into office
routines.
Studies have found that
standing orders alone resulted
in a 16% increase in
vaccination rates.
A comprehensive
immunization alerts (age, time,
and risk-based) for eligible
adult patients incorporated into
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the clinics’ EMRs increase
efficiency and may be more
effective than ad hoc
administration of adult
vaccines.

were provided to
each site to
support their
internal
initiatives.

Capitano
Grade: B
et al., 2018
Level: III

Sixty-seven
clinical
pharmacists
participated in
the survey,
completing a
combined total of
94 surveys, and
representing 61
distinct
institutions.
Evaluable
surveys were
completed for 56
inpatient and 38
outpatient sites.
Participating
practice sites
were located
across 29 states,
most of which
were in the
Midwest,
Northeast, and
Mid-Atlantic
regions of the
continental
United States.

Assess existing
pneumococcal
immunization
protocols (PIPs)
to determine: (a)
whether
protocols exist
for high-risk
adults across
diverse clinical
settings; (b)
whether the
existing
protocols were
concordant with
the 2012 ACIP
recommendations
at the time of the
study; and (c) to
identify
additional
strategies to
improve ACIP
recommendation
implementation
in adults.
Completion of
the survey

Cross sectional
study.
Nonexperimental
Descriptive
study.
This was a
multicenter,
cross-sectional
survey of
clinical
pharmacist
members of the
American
College of
Clinical
Pharmacy
Practice-Based
Research
Network
(ACCP PBRN)
conducted from
September
2014 to May
2015.

Fifty percent
(19/38) of
outpatient sites
reported their
pneumococcal
immunization
program to be an
alternative
practice or
nonstandardized
approach to
immunization
whereby patients
are assessed for
and receive a
pneumococcal
vaccine
independent of a
standardized
protocol or
process.
Our study
demonstrates that
only 36% (34/94)
of all clinical
practice sites
providing care for
adults at high-risk

Assessment whether
pneumococcal immunization
protocols (PIPs) exist for highrisk adults across diverse
clinical settings, determined
protocol concordance with the
2012 ACIP recommendations,
and identified tactics to
improve ACIP
recommendation
implementation.
Twenty-five of the 45 inpatient
PIPs (56%) were concordant
with ACIP recommendations.
Half of the outpatient sites did
not have a standardized, written
PIP in place. Of the 17
evaluable outpatient PIPs, 9
(53%) were concordant with
ACIP recommendations.
The most common perceived
barriers to ACIP recommended
immunization in adults were a
lack of knowledge regarding
national recommendations, a
lack of accountability for
recommendation
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Most inpatient
sites were
private, nonprofit
teaching
institutions as
were most
outpatient clinics
which were
likely affiliated
with the inpatient
institutions

required
pharmacist
respondents to
access and obtain
institutional,
outpatient clinic,
and/or health
system related
information from
electronic
resources, as well
as through
conversations
with multiple
parties involved
with vaccines at
the local level.
The survey was
administered
using REDCap
(Vanderbilt
University,
Nashville,
Tennessee).8
Data were
analyzed using
descriptive
statistics,
stratified by
inpatient or
outpatient
setting, using
IBM SPSS
Statistics v.22
(IBM Corp.,
Armonk, New
York)

of pneumococcal
disease had
adopted the 2012
ACIP
recommendations
into standard
immunization
practice 2 years
following the
publication of
these
recommendations.
The authors
concluded that the
implementation of
computerized
standing orders
was most
effective as
significantly more
patients received
pneumococcal
immunization
compared with
electronic
physician
reminders (51%
vs 31%,
respectively, P <
0.001). Another
effective strategy
for enhancing
immunization
rates is a
recommendation
from a health care
provider,

implementation, and outdated
PIPs.
Only 36% (34 out of 94) of the
clinical sites had adopted the
ACIP recommendations.
A gap clearly exists in the
implementation of national
immunization
recommendations to prevent
pneumococcal disease in highrisk adults
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including patients
with a negative
attitude toward
vaccines

DeHart,
2005

Grade: B
Level: III

Short policy
survey was sent
in 1999 and 2001
to all Washington
State nursing
homes; In 1999,
269 facilities
received the
survey, and in
2001, 257
facilities received
it. Facilities that
had closed were
removed from
the lists.

Survey was faxed
back after mailed
to facility
administrator.
Survey included
questions about
standing order or
guidelines for
administration of
PPSV23 vaccine,
barriers to
inoculation, staff
members
involved with
vaccine
compliance and
Sample: residents policy.
aged 65 years
Samples were
and older.
selected from
nursing home
Year 2000 =
residents listed in
17,500 residents the Centers for
(random sample). Medicare &
Year 2002 =
Medicaid
1,487 (random
Services (CMS)
sample).
required
Minimum Data
Descriptive
Set (MDS).
statistics were
Assessments are
used to
conducted

Nonexperimental
descriptive
study. Cross
sectional
survey (19992001).

Response rates for
the policy
assessment
surveys were
99.6% and 100%
for 1999 and
2001,
respectively. In
1999, 58.2% of
the nursing homes
reported having
either standing
orders or written
guidelines for
administering
pneumococcal
vaccine to their
residents. This
percentage rose to
72.0% in 2001, a
statistically
significant
difference (χ2 =
10.9, P < .001).
There was a
significant
increase in the
percentage of
residents who had

Those most often responsible
for overseeing policy
compliance at facilities that
reported using standing orders
or written guidelines were the
infection control practitioner
(56%), the director of nursing
(37%), and other licensed
nursing staff (20%).
Abstraction forms with
pneumococcal vaccination
information were received for
1444 of the sampled residents
in facilities that remained open
in 2000 and for 1092 residents
in 2002 for response rates of
80% and 73%, respectively.
The use of standing orders or
other written guidelines by
nursing homes in Washington
State increased 14% from 1999
to 2001. At the same time, the
pneumococcal vaccination
coverage rate for residents of
those facilities also increased
14%.
The increased use of standing
orders/written policies has
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characterize
nursing home
policies and
practices and
residents’
vaccination
status. Chisquare tests were
used to compare
percentages of
standing
orders/guidelines
and vaccination
status between
the time periods.
We used logistic
regression to
assess whether
the presence of
standing orders
was associated
with number of
beds per facility.
Odds ratios
showing the
association
between
facilities’
standing
orders/guidelines
and residents’
pneumococcal
vaccination
status were
calculated using
logistic
regression-based

regularly by the
facilities and
compiled into the
MDS quarterly.

received
pneumococcal
vaccination in
2002 compared
with 2000 (χ2 =
48.86, P < .0001).
In both 2000 and
2002, the odds of
a resident
receiving a
pneumococcal
polysaccharide
vaccine (PPV) in
a nursing home
having standing
orders or other
written guidelines
are estimated to
be two-and-a-half
times greater than
for residents in
facilities without
any PPV
guidelines (2000:
OR = 2.59; 95%
CI, 1.54–4.34;
2002: OR = 3.19;
95% CI, 1.68–
6.01).

contributed to higher rates of
pneumococcal vaccination in
Washington State nursing
homes. It is hoped this will, in
turn, lead to lower risks of
death from pneumonia in this
vulnerable population.
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generalized
estimating
equations with an
exchangeable
correlation
structure, logit
link, and
binomial error
distribution. All
data analyses
were done using
SAS System for
Windows,
Release 8 (SAS
Institute Inc.,
Cary, NC).
Gamble,
2008

Grade: B
Level: II
Design: control
trial.

Sample: 3
primary care
outpatient clinics
for adults 65
years and older.

Focus: Describe
Nonrandomized Pneumovax
one experiment
immunization
to minimize the
Quasirates were
costs of adopting
substantially
and
experimental.
lower than the
implementing an
influenza
SOIP in several
immunization
outpatient clinics.
rates in the
Clinic criteria
baseline period,
included a
with 13% to 35%
caseload of at
in the study
least several
clinics. There
hundred patients
were no
aged 65 years or
statistically
older; the
significant
absence of a
changes from the
formal, written
baseline to the
SOIP for
postintervention
influenza or
period.
pneumonia, and a

Systematic review strongly
suggests that systems
interventions, especially
standing order immunization
policies (SOIPs), whereby a
nurse or other health care
provider is authorized to
administer vaccinations
according to an institution- or
physician-approved protocol,
are among the most effective
and efficient ways to increase
immunization rates for
pneumococcal.
Research has also shown SOIP
to be effective in a variety of
settings including hospitals,
emergency rooms, nursing
homes, and outpatient clinics.
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willingness to
adopt and
implement such a
policy.
Strategy:
-Initial meeting
with lead
physicians and
nurses who
would support
the policy change
to discuss
strategies for
implementation
unique to each
setting.
Sharing a model
SOIP with the
clinics to
facilitate their
own adoption of
a written policy.
● Ensure that
clinics have
immunization
flow sheets for
vaccination
recording and
share model
forms with them
if necessary.
● Provide lunch
to staff,
especially nurses,
at the beginning
of the program
and explain

To assess the
efficacy of the
flow sheets, we
compared the
immunization
rates of patients
with and without
flow sheets. The
flu immunization
rate for those who
had a flow sheet
in their medical
chart was quite
high in both time
periods, ranging
from 93% to
100% (Table 2).
For eligible
patients without
flow sheets, the
comparable rate
was 9% for all the
clinics in both
time periods.
Slight increases in
the immunization
rate from the
baseline to
postintervention
periods were not
statistically
significant.

The introduction and adoption
of an SOIP can be an important
step to increasing immunization
rates, but the results from this
study highlight the critical
importance of the entire
implementation and monitoring
process in making this policy
effective.
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program
objectives and
procedures,
answer questions,
and assess any
unexpected
barriers. ●
Conduct a final
interview with
the head nurse in
each clinic at the
end of the
program period
to learn how the
policy was
implemented,
monitored, and
followed during
the year.
To measure the
change in
immunization
rates before and
after the SOIP
implementation,
a chart review for
the year before
the intervention
(1999) was
compared with a
similar review
for the year of
the intervention
(2000).
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Smith,
2011

Grade: A
Level: II
Design: Quasi-

Sample: random
selection of 300
patients.
Adults 65 years
and older.

experimental
Setting: hospital.

Intervention:
multifaceted
pneumococcal
vaccine protocol.
Eligibility
determined by
CDC guidelines
and medical hx.

Quality
improvement
project.
Descriptive
statistics.

The project’s
primary quality
To determine the measure
impact of a
compared
multifaceted
pneumococcal
intervention on
vaccine
pneumococcal
administration
vaccine
in eligible
screening and
patients
administration
admitted to 2
rates in eligible
internal
patients
medicine units
according to the
before and after
CDC
implementation
recommendations of the vaccine
who were
initiative.
admitted to an
A pre-test/postinternal medicine test study using
unit of a tertiary
electronic
care teaching
medical record
hospital.
review was
conducted
retrospectively
for randomly
selected adult
patients
admitted to 2
internal
medicine units
at the study

The rate of
pneumococcal
vaccine
administration in
eligible patients
significantly
improved postimplementation
compared with
preimplementation
(74.2% vs. 19.1%,
respectively, P=
0.203.

Implementation of vaccine
protocol changes was
associated with improved
pneumococcal vaccination rates
in eligible patients.
Protocols were easy to
implement in a large institution,
and a similar approach may be
implemented in other settings
as an effective way to improve
vaccination rates.
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Nace et
al., 2017

Grade: B
Level: III
Design: Nonexperimental Descriptive

Discussion of
importance of
pneumococcal
vaccination for
adults,
recommendations
for vaccination
practices,
procedures, and
guidance for
effective
implementation
of pneumococcal
vaccine policies.

Survey of
practitioners at
post-acute and
long-term
centers.
Promotion of
standing order
programs.
Promulgating
immunization
standards.
Transparent
reporting of
pneumococcal
vaccine rates.
Survey protocol
for
pneumococcal
vaccination.
Tools to support
providers in
efforts to
improve
pneumococcal
vaccination rates:
a pneumococcal
vaccination
guidance, a
pneumococcal
vaccine coverage
guide, a resident

institution
during the
specified study
periods.
Qualitative
research.

Barriers to
vaccination: poor
access to
vaccines, lack of
education,
healthcare
workers behavior
and attitudes,
cultural factors,
and cost.
Surveyors
reported
skepticism to
benefits of
vaccine.
Frailed patients
could be
attenuators of
vaccine response.
Strong
recommendations
to establish and
maintain a
pneumococcal
vaccination
program
according to
ACIP guidelines.
Ongoing
assessment of
established
vaccine program
to monitor if

Research reveals standing order
programs to be effective in
improving immunization rates
in a variety of settings however
not widely adopted leading to
rates below targets.
Low targets triggered CMS to
set new immunization
standards in post-acute and
long-term centers.
PPSV23 not as effective in
geriatrics, it still provides
significant health benefits.
Facilities should enhance ways
to obtain accurate vaccine
history before discharge.
Pneumovax is covered by
Medicare recipients as a part B
benefit.
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pneumococcal
vaccine
assessment note
via use of a
template.

Sebald et
al., 2018

Grade: B
Level: II
Design: Quasi
experimental.

Setting:
communitybased internal
medicine resident
clinic.
Sample: 50
patients.
Aim: QI project
aimed to develop
and test a
systematic
vaccination
review and
ordering protocol
aimed to increase
the percentage of
assessed clients
under
pneumococcal
practice by 5%.

Vaccination
assessment
protocol by
reviewing EHR.
Phase I involved
initial estimate of
the overall
baseline
vaccination
assessment rate
in the resident
clinic, the
authors randomly
selected a sample
of 50 random
patient
encounters and
reviews of their
pneumonia
vaccination
status was
determined.
Phase II:
implementing an
internally
developed
pneumococcal
vaccination
assessment and

Quality
improvementProspective
interventional
before and after
nonrandomized
study.

vaccine rates fall
below U.S.
Department of
health Human
Services goals.
Tools developed
are free of cost
and found online.
Outcome:
Based on initial
results, our
pneumococcal
vaccination
protocol may have
helped facilitate
improved
adherence to the
national CDC
guidelines.
Unfortunately, it
appeared to be
difficult to
maintain staff and
physician
compliance with
our protocol.

Identification of clients needing
a pneumococcal vaccine
increased by 10%.
This study group found that
automatically generated
physician orders were much
more effective in increasing
pneumococcal vaccination rates
than EHR reminders to order a
pneumococcal vaccination.1
EHR-generated order set for
the pneumococcal vaccination
might have been more
successful to prompt provider
assessment of patients’
pneumococcal vaccination
status
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ordering
protocol, this
vaccination
assessment rate
was again
measured from
another random
sample.
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Appendix B
Summary of Systematic Reviews (SR)
Citation Qualit Question
y
Grade
Lau,
Grade: Aim: Reviewed
2012
effectiveness of QI
B
Level: interventions for
increasing the rates of
II
influenza and
pneumococcal
vaccinations in adults
(elderly primary care
patients).

Search
Strategy

Inclusion/
Exclusion Criteria

Data Extraction Key Findings
and Analysis

Systematic
Review of
RCT and nonRCT and
Meta-Analysis

Community dwelling adults Authors results:
Nurse autonomy to
or high-risk nonelderly
(1) shifting vaccine administer vaccines
patients. Settings: primary
administration from with standing orders
care practices (41 studies), physicians to
would impact vaccine
community practices (21),
members of the
rates.
managed care organizations primary care team Studies that
(13), Medicare affiliated
(nurses) with clear considered posters
organizations (11) and
responsibilities for alone in waiting and
Veterans Affairs medical
chronic and
examination rooms
centers (8). There were 48 preventive care and were not significantly
comparisons from 35 studies (2) activating
associated with
included in the Metapatients through
vaccination rates.
analysis.
personal outreach
Primary setting.
may stand the best Team changes were
Adults and high-risk adults. chance of
more effective to
improving
improve
vaccination rates in pneumococcal and
community dwelling influenza vaccination
adults.
rates in association
with personal contact.
SOP and face to face
Interventions
interaction.
associated
Patient incentives also
w/improvements: proved effective
Odd ratio (OR) =
1.61, 95 % CI.
Flu: OR =1.46, 95%
CI.
Pneumococcal: OR
2.01; 95% CI

Usefulness/Re
commendation/
Implications
Interventions
featuring clinician
reminders, team
change, and
patient outreach
had the highest
ratios.
Clinician
education and
case
management also
yield
improvements in
pneumococcal
vaccination rates.
Office brochures
at the point of
care were 3.87
times more
effective than
mailed reminders
for pneumococcal
vaccines.
we found that
having nurses
assume
responsibility for
administering
vaccinations was
effective, whereas
interventions in
which nurses or
pharmacists
assessed patients
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Citation Qualit Question
y
Grade

Search
Strategy

Inclusion/
Exclusion Criteria

Data Extraction Key Findings
and Analysis

Usefulness/Re
commendation/
Implications
and reminded
physicians, but
did not
themselves
administer
vaccinations,
were ineffective.

Legend:
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Appendix C
Project Schedule
Project Title: Adult Pneumococcal Vaccine Program and Competency-based orientation.
Project Leader: Magda Angel, MSN, RN, PHN

x

x

x

x

x

x
x
x

Week 15

Week 13

x

x

Week 11

x

x

Week 9

x

x

Week 7

x

x

Week 5

x

Week 3

x

Week 1

x

Week 15

x

Week 13

x

Week 11

x
x

Week 9

x
x
x
x

Week 7

x

NUR7803

Week 5

x

Week 3

x

Week 1

x

Week 15

Week 11

x

Week 13

Week 9

x

Week 7

x
x

Week 5

Week 1

Meet with preceptor
Project identification
Prepare project
proposal
Literature Review
SWOT analysis
Attend EBP workshop
Stakeholder
determination
EPRC approval
IRB determination
Education Session
with staff (30 min).
Quiz pre-presentation
Post PowerPoint
presentation
competency quiz
Run weekly report on
pneumococcal
vaccines administered
in EHR dashboard.
Weekly data collection
Weekly EHR data
collection
Run weekly report on
pneumococcal
vaccines administered
in EHR dashboard.
Revision of alternative
Project
Analyze results of new
evidence
Appraisal of Evidence,
recommendation
statement

NUR7802

Week 3

Activity

NUR7801
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x

Week 15

x

Week 13

Week 11

Week 7

Week 5

Week 3

Week 1

Week 15

Week 13

Week 11

Week 9

Week 7

NUR7803

Week 5

Week 3

Week 1

Week 15

Week 13

Week 11

Week 9

Week 7

Week 5

Week 3

NUR7802

Week 9

Program Analysis and
evaluation plan
Preview of Toolkit
Activity program
analysis
Program evaluation
discussion and
recommendations
Review manuscript
submission
Archival to SOAR
Presentation

Week 1

Activity

NUR7801

x
x
x
x

x
x
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Appendix D
Chart Audit Data Collection Form
Subject ID (Unidentified code)
Retrospective Data
Demographics
Age:
a) 19-64 years
b) 65 years and older
Gender:
0. Female
1. Male
2. Nonbinary
Ethnicity
0. White/Caucasian
1. African American/Black
2. Hispanic
3. Asian
4. Other
Pneumococcal vaccine assessment performed during nurse visit?
a) Assessed
b) Not assessed
Patient inoculated with PPSV23 or PCV13 using nurse driven protocol?
a) Vaccinated
b) Refused vaccination
Nurse conducting nurse visit
1. Nurse A
2. Nurse B
3. Nurse C
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Appendix E
Annual Competency for Nurses of Adult Vaccine Program
1) Where can you reference the latest update of the adult pneumococcal vaccine guideline:
a) Centers for Disease Control and Prevention
b) Health entity portal
c) Doctors note
2) What are the four standards to improve vaccine administration recommended by the CDC’s Standards for
Adult Immunization Practice:
a) Assess, recommend, administer, and document
b) Assess, not administer, set reminders, refer to outside provider
c) I don’t know
3) In case of an Adverse Reaction, who do you submit a report to:
a) CDC Vaccine Adverse Event Reporting System
b) Internal Reporting system
c) Document in the electronic health system
4) After assessment of the electronic health system, you identify the need for a pneumococcal vaccine, how do
you obtain the order for the vaccine?
a) Ask the doctor to sign the order
b) Have the patient return a different day until the doctor signs the order.
c) Order the vaccine using the nurse-driven vaccine order policy then administer proceed to inoculate.
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Appendix F
Nurse Visit Workflow

•
•
•

Assess
•
•
•
•

Strongly recommend vaccine
Address any questions or concerns
in lay terms
Share professional and personal
positive experiences
If agreeable, provide vaccine
information sheet (VIS) for review

Review Vaccine status
Reconcile vaccines as needed
Run Immunization registry

Recommend
•
•
•
•
•

Administer

Order pneumococcal vaccine using nurse
driven protocol
Follow standard hand hygiene
Scan vaccine if device available
Administer vaccine
Monitor patient for 15 min for adverse
reaction per CDC recommendations

Document
•
•
•

Document vaccine in electronic health record
Provide a written document with vaccine
information (record)
Schedule appointment for next dose if
applicable
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Appendix G
Proposed Policy: Nurse-Driven Pneumococcal Vaccine Protocol
POLICY STATEMENT/SCOPE:
To reduce morbidity and mortality from pneumococcal disease by vaccinating all eligible adults
using a nurse-driven vaccine order to patients who meet the criteria established by the Centers
for Disease Control and Prevention (CDC) and the Advisory Committee on Immunization
Practices (ACIP).
I. DEFINITIONS:
a) Shared clinical decision-making (SCDM)- recommendation made based on the
patient’s risk for exposure to PCV13 serotypes and the risk for pneumococcal disease for
that person because of underlying medical conditions.
II.
POLICY:
All eligible nurses (i.e., RN and LVNs) may vaccinate eligible adults in ambulatory settings
using this standing order who meet the criteria below.
III.
PROCEDURES AND RESPONSIBILITIES:
a) Identify adults in need of inoculation with pneumococcal conjugate vaccine (PCV13) or
pneumococcal polysaccharide vaccine (PPSV23) based on criteria (see Attachment A
and B).
a. PPSV23 is recommended for all adults aged 65 years and older with no or
unknown history of prior receipt of PPSV23.
b. PPSV23 is recommended for all adults aged 65 years and older received PPSV23
before age 65 years.
c. PPSV23 is recommended for adults 19-64 years with no or unknown history of
prior receipt of PPSV23 and any of the conditions outlined in the table (see
Attachment A and B).
d. PCV13 is no longer routinely recommended for all adults. Shared clinical
decision making is recommended (see Attachment A and B).
e. PCV13 is recommended for adults 19-64 years with no or unknown history of
prior receipt of PCV13 and any of the conditions outlined in the table (see
Attachment A and B).
b) Screen all patients for contraindications and precautions to pneumococcal vaccine and
refer any of these or other issues to a physician for further evaluation. Do not give
PCV13 and PPSV23 at the same time.
a. Severe allergic reaction (anaphylaxis or any symptoms other than hives) after a
previous dose of PCV13 or PPSV23, or to a vaccine component.
b. Moderate or severe acute illness with or without fever
c. Syncope (fainting) can occur in association with administration of injectable
vaccines.
c) Provide patient with the most current Vaccine Information Statement (VIS) from the
CDC in a written or electronic form.
Pneumococcal Polysaccharide Vaccine Information Statement | CDC (see Appendix H)
Pneumococcal Conjugate Vaccine Information Statement | CDC (see Appendix I)
Centers for Disease Control and Prevention. (2021, May 27). Use of agency materials.
https://www.cdc.gov/other/agencymaterials.html
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Input order as standing order in patients’ electronic health record (EPIC).
Use scanning device to auto populate vaccine lot number, expiration date and VIS date.
Administer pre-filled vaccine to deltoid muscle.
Notify physician of any adverse reactions post administration.
h) Report all adverse reactions following administration to the Vaccine Adverse Event
Reporting System (VAERS). Reports can be submitted to VAERS online or fax. For
assistance, please email infor@VAERS.org or call 1-800-822-7967.
d)
e)
f)
g)

Centers for Disease Control and Prevention. (2021, May 27). Use of agency materials.
https://www.cdc.gov/other/agencymaterials.html

PROGRAM EVALUATION CBO TOOLKIT

79

Appendix H
Competency Based Orientation Toolkit
Purpose Statement
This CBO toolkit is designed to help orient new nurse hires execute proper vaccine needs
assessment of an electronic health record, decrease missed opportunities, advise adults on the
pneumococcal vaccine, and increase pneumococcal vaccine uptake.
Audience
This CBO toolkit is intended for the following audiences in mind:
•

New nurse hires orienting in vaccination clinics.

•

Nurses interested in quality improvement projects that enhance immunization services.

•

Ambulatory health care professionals interested in improving vaccine administration
services.

•

Nurse vaccine champions

Definitions/Glossary
•

AVP: Adult Vaccine Program

•

CBO: competency-based orientation

•

EHR: Electronic health record

•

PPSV23: Pneumococcal Polysaccharide Vaccine 23-valent

•

PCV13: Pneumococcal Conjugate Vaccine 13-valent

•

VPD: Vaccine Preventable Disease

•

Nurse-driven vaccine protocol: approved protocol policy that allows qualified nurses to
order and administer vaccines based on CDC guidelines.

•

VAERS: Vaccine Adverse Effects Reporting System

•

SCDM: Shared clinical decision-making: recommendation made based on the patient’s
risk for exposure to PCV13 serotypes and the risk for pneumococcal disease for that
person because of underlying medical conditions.

•

RN: registered nurse

•

LVN: licensed vocational nurse
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Implementation Strategy
The following is an overview on how adult vaccine programs using nurse-driven protocols can
increase pneumococcal vaccine uptake among adults 65 years and older. Integration of nursedriven protocols and following a standard immunization practice reduces the rate of missed
opportunities to vaccinate. The Centers for Disease Control and Prevention (CDC) support the
use of evidence-based interventions that increase the rate of vaccine rates during clinical visits.
•

Integrate a nurse-driven pneumococcal vaccine protocol to the AVP.

•

Recommend a nurse template to guide nurse visit. Template to include CDCs Standards
for Adult Immunization Practice.

•

Train and educate staff on CDCs pneumococcal vaccine guideline.

•

Review nurse visit workflow (Appendix F)

•

Review health policy on nurse-driven vaccine (Appendix G)

•

Partner new hire nurse with a preceptor for 2 weeks.

•

Review best practices on injection safety and administration.

•

Review appropriate use of hand hygiene.

•

Review how to report a VAERS report

Staff
The following key stakeholders are vital for the implementation and sustainability of the AVP.
See role and responsibility:
•

Nurse preceptors: responsible of new hires orientation.

•

Clinical practice manager: to support the implementation of the program and facilitate
available resources to sustain program.

•

Nurse vaccine champion: to coordinate adult vaccine program and update vaccine
guidelines as needed. Support preceptors and new nurse hires during the orientation
process and life of the adult vaccine program.

•

Medical Director: to revise, approve, and update vaccine policy as needed.

•

Informatics/Analytics: will support with data reports to show vaccine rates.
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Evaluation strategy and tools
•

Nurse vaccine champion to perform monthly chart audits (Appendix D)

•

Nurse champion to perform annual competency assessment (Appendix E)

•

Collect baseline data and report to team monthly rates during staff meetings.

•

Update huddle board weekly with data (vaccine rates).

•

Nurse preceptor to utilize Immunization Action Coalition skills checklist to support new
hire with performance evaluation Skills checklist

Stakeholder engagement and analysis tools
•

Patients Handouts: provide the vaccine information sheet and vaccine fact sheet to
support decision making

•

Nursing staff: provide the CDCs Standards for Adult Immunization Practice Standards
for Adult Immunization Practice

•

Increase awareness on adult immunization programs Overview on Adult Immunization
Practice

•

Report vaccine rates and percentage of nurse-driven protocol utilization during staff
meetings.

•

Provide baseline data on pneumonia infection rates among adults 65 years and older
currently hospitalized for selected health system.

•

Display organization goal for pneumococcal vaccine rate.

Communication planning tools
Vaccine champion will inform all staff about the adult pneumococcal vaccine program and CBO
toolkit. Discuss the purpose of the program, impact of workflow, and resources available to
support nurses. Possible formats of communication:
•

Email

•

Staff meetings

•

Huddles
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•

Microsoft Teams

•

Informal communication during rounds.
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Policy/purpose statement:
To reduce morbidity and mortality from pneumococcal disease by vaccinating all eligible adults
using a nurse-driven vaccine order who meet the criteria established by the Centers for Disease
Control and Prevention (CDC) and the Advisory Committee on Immunization Practices (ACIP).
See Appendix G for detailed policy.
•

This order authorizes registered nurses (RNs) and licensed vocational nurses (LVNs)with
active licenses in California to order and administer pneumococcal vaccines.

Education Materials
These forms are periodically updated and you should verify if you have the most current. Below
is a list of the forms and links to the most current:
Staff/clinicians:
•

Review the CDCs injection safety checklist Injection Safety Checklist

•

Safe Injection Practices- How to Do it Right [YouTube video] Safe Injection Practices

•

How to submit a VAERS report online VAERS report

•

CDC Pneumonia website CDC Pneumonia

•

Hand Hygiene [YouTube video] Proper Handwashing

•

Medical management of vaccine reactions in adults in a community settings Management
of vaccine reactions

•

Screening checklist for contraindications to vaccines for adults Screening for
contraindications

•

Vaccine Administration: Intramuscular (IM) Injection Adults 19 years of age and older
You Call the Shots

•

Nurse Visit Workflow (Appendix F)
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•
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Pneumococcal ACIP Vaccine Recommendations Morbidity and Mortality Weekly Report
(MMWR)

•

Steps to Improve Adult Immunization Practices Vaccine Needs Assessment

Patient/client/support member
•

CDC Pneumonia website Pneumonia Can Be Prevented - Vaccines can help

•

Vaccine Information Sheet Pneumococcal Conjugate Vaccine VIS

•

CDC Handout Pneumococcal Disease in Adults and the Vaccines to Prevent It

•

Alliance for Aging Research [YouTube] Our Best Shot: The Importance of Vaccines for
Older Adults

Evaluation Tools/CBO document
•

Injection Safety Checklist Injection Safety Checklist

•

Immunization Action Coalition Skills Checklist Skills checklist

•

Nurse vaccine champion to perform monthly chart audits (Appendix D)

Scenario Examples of Process in use.
Virginia Department of Health (VDH)

Source

NurseDriven
and/or

California Department of Public
Health
California Department of Public
Virginia Department of Health. (2022, January
Health. (2019, October).
14). Standing order for dispensing and
Recommendations for the
administering Covid-19 vaccine.
Prevention and Control of Influenza
https://www.vdh.virginia.gov/content/uploads/sit in California Skilled Nursing
es/134/2021/04/COVID-Vaccine-StandingFacilities (SNF).
Order.pdf
https://www.cdph.ca.gov/Programs/
CHCQ/HAI/CDPH%20Document%
20Library/RecommendationsForThe
PreventionAndControlOfInfluenzaN
ov2018_FINAL.pdf#search=pneumo
coccal%20vaccine%20standing%20
order
• Registered nurses (RNs) and licensed practical • Obtain standing vaccination orders
from providers for each resident
nurses (LPNs} actively licensed in Virginia
before influenza season begins.
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Pharmac
istDriven
Vaccine
protocol.

who are in good standing to practice in
• Obtain standing order for
pneumococcal vaccine for residents.
Virginia per the Virginia Board of Nursing to
• Vaccinate residents.
administer FDA authorized COVID-19
• HCP: healthcare personnel to
vaccines at community vaccination events
administer vaccines using standing
• Pharmacists actively licensed in Virginia who
order.
are in good standing to practice in Virginia
per the Virginia Board of Pharmacy to
dispense and administer FDA-authorized
COVID-19 vaccines.

Purpose

To reduce morbidity and mortality from
COVID-19 (SARS-CoV-2) by vaccinating
persons who meet the criteria authorized by the
Food and Drug Administration (FDA)
Emergency Use Authorization (EUA) and in
accordance with the Centers for Disease Control
and Prevention's (CDC} Advisory Committee on
Immunization Practices (ACIP)
recommendations. This order is intended to
supplement existing authorization under the
Public Readiness and Emergency Preparedness
(PREP) Act.
• Screen for any vaccine precautions and
contraindications using an appropriate prevaccine questionnaire before administering the
vaccine.
• Provide vaccine recipient with copy of current
fact sheet.
• Provide with v-safe information sheet to
recipient.
• Obtained informed consent of the patient or
parent, guardian.
• Answer all questions. Educate on about where,
how, and when to obtain the additional Covid19 vaccination.
• Appropriate medical treatment and clinical
staff able to manage immediate allergic
reactions in the event of adverse reaction.
• Administer vaccine intramuscularly.
• Monitor post-vaccination for at least 15
minutes.
• Report any vaccine administration errors to
VAERS system.

Process/
Procedu
re

The document includes specific
guidance for SNF leaders to develop
a plan for an effective influenza
prevention program in advance of
the influenza season (October 1March 31) and for evaluating a
season’s experiences upon
completion of influenza season.

• Educate about impact of influenza
on residents and importance of
preventing illness, complications,
and outbreaks.
• Develop or update the influenza
vaccination plan for residents
according to ACIP
recommendations.
• Schedule additional doses of
pneumococcal vaccine as needed.
• Track each resident’s vaccination
status and room location.
• Calculate vaccination rates.
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• Record vaccination in the pharmacy or medical
record within 24 hours and to the Virginia
Immunization Information System.
• Provide vaccine recipient with a personal
vaccine record.
• Schedule next dose before individual leaves the
site.
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Forms

Immunization Action Coalition. (2022, March 14). Immunization action coalition disclaimer.
https://www.immunize.org/iacadmin/disclaimer.asp
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Centers for Disease Control and Prevention. (2021, May 27). Use of agency materials.
https://www.cdc.gov/other/agencymaterials.html
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Centers for Disease Control and Prevention. (2021, May 27). Use of agency materials.
https://www.cdc.gov/other/agencymaterials.html
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Centers for Disease Control and Prevention. (2021, May 27). Use of agency materials.
https://www.cdc.gov/other/agencymaterials.html
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Centers for Disease Control and Prevention. (2021, May 27). Use of agency materials.
https://www.cdc.gov/other/agencymaterials.html
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Immunization Action Coalition. (2022, March 14). Immunization action coalition disclaimer.
https://www.immunize.org/iacadmin/disclaimer.asp
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Immunization Action Coalition. (2022, March 14). Immunization action coalition disclaimer.
https://www.immunize.org/iacadmin/disclaimer.asp
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Centers for Disease Control and Prevention. (2021, May 27). Use of agency materials.
https://www.cdc.gov/other/agencymaterials.html
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Centers for Disease Control and Prevention. (2021, May 27). Use of agency materials.
https://www.cdc.gov/other/agencymaterials.html
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Centers for Disease Control and Prevention. (2021, May 27). Use of agency materials.
https://www.cdc.gov/other/agencymaterials.html
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Centers for Disease Control and Prevention. (2021, May 27). Use of agency materials.
https://www.cdc.gov/other/agencymaterials.html
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